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Abstract 
Title: A study to assess the effectiveness of Yellow myrobalan (kadukkai) 
powder dressing on wound healing in clients with diabetic foot ulcer in 
selected wards at Rajiv Gandhi Government General Hospital, Chennai. 
Diabetes is the global epidemic problem with devastating human, social 
and economic consequences. Diabetic foot ulcer is the most serious and costly 
complications and important cause of morbidity in diabetic people over the years. 
Need for the study: The recent statistical data shows that diabetic foot ulcers are 
suggest that around 10% of people with diabetes develop foot ulcers. Foot 
ulceration is the precursor to approximately85%of all diabetic amputations and it 
is estimated that14%- 20%of clients with foot ulcers will have to undergo 
amputation infection. So different treatment modalities needed to care and 
minimize the complications of diabetic foot ulcer, thus provoked the researcher to 
do this study. 
Objectives 
 To assess the grading level of diabetic foot ulcer among clients  
 To evaluate the effectiveness of yellow myrobalan (Kadukkai)powder 
dressing on wound healing among experimental group as post-test. 
 To compare the wound healing process between experimental and control 
group. 
 To find the association between wound healing process and Kadukkai 
powder dressing with selected demographic variable among experimental 
group. 
Key words  
 Effectiveness, Yellow Myrobalan (Kadukkai) powder dressing and diabetic 
foot ulcer. 
Research Methodology 
Research Approach:  Quantitative research approach 
Study setting: In selected wards at Rajiv Gandhi Government General Hospital 
Chennai.  
Research design   : True experimental study. 
Study population : clients with diabetic Foot ulcer admitted in selected wards at  
Rajiv Gandhi Government General Hospital Chennai. 
Sample size: Total 60 samples 
Sampling technique    : Simple random sampling 
Sampling tool              : Wagner Wound Assessment Tool 
Data collection procedure:A formal written permission was obtained from 
selected departments, the study purpose and method was explained to all subjects 
and informed written consent obtained, the information regarding demographic 
profile and clinical related information were collected from 60 diabetic foot ulcer 
subjects, subjects were assessed both experimental and control group based on the 
Wagner Wound Assessment Scale in pretest and posttest, routine care was not 
altered and also I spend 30minutes for each subjects. 
Data Analysisdata were analyzed by using,descriptive statistical analysis (mean, 
standarddeviation, frequency and percentage to describe the demographic 
vaULDEOHV RI GLDEHWLF IRRW XOFHU DQG LQIHUHQWLDO VWDWLVWLFDO DQDO\VLV SDLUHG µW¶WHVW
chi-square test). 
Study results:The effectiveness of Yellow Myrobalan (Kadukkai) powder 
dressing on wound healing among clients with diabetic foot ulcer, the percentage 
of dressing score with 95% confidence interval in experimental group 
25.4%(19%-31.2%). 
Discussion Kadukkai powder dressing with diabetic foot ulcer subjects shows  
a significant result when compared to the routine care group and hence the 
hypothesis is proved. 
Conclusion The diabetic patient with foot ulcer in the Experimental group had 
improved the wound healing activity and thereby faster wound healing of the foot 
ulcer. 
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     CHAPTER - I 
                                    Introduction 
µµ7KHPRVWLmportant Practical lesson that given to nurses is to 
WHDFKWKHPZKDWWRREVHUYH¶¶ 
Florence Nightingale 
  Healthy life is the valuable gift of an individual, if a person is healthy 
enough according to me he is the richest person in his own world. But there is 
certain disease condition which affects the normalcy of many of a people in our 
existing world. Such as heart problems, neurological problems, orthopedic 
problems, metabolic disorders especially diabetes mellitus, etc., among which 
GLDEHWHVLVRQHRIWKHPRVWLPSRUWDQWKHDOWKLVVXHLQWRGD\¶VZRUOGZKLFKPD\
affect the entire life pattern of an individual. 
  World diabetes foundation in 2014, estimated that 360 million people 
worldwide have Diabetes mellitus responding roughly 9% of adult population 
of 40-70 years. The number is expected to reach 552 million by 2030 
representing 11% of the adult population. 
 Diabetes is the global epidemic problem with devastating human, social 
and economic consequence. Diabetes is the third leading cause of death by 
disease globally and accounts for 50% of total death annually. 
Diabetes mellitus is the leading cause of death by disease because of its 
high rate of cardio vascular involvement and morbidity, The economic cost, 
hospitalization rates for direct and indirect treatment and care increase day by 
day. It is also a complex disorder with profound consequences both acute and 
chronic. Genetic and environment factors play a role in the development of the 
disease. 
The Diabetes mellitus is a pan metabolic, vascular and tri hormonal 
disorder due to insulin deficiency or insulin résistance, glucagon excess, 
incretin deficiency characterized by chronic hyperglycemia which may lead to 
acute and chronic complications. Diabetes mellitus is the commonest form of 
diabetes constituting 90% the diabetes population. The global prevalence of 
diabetes mellitus is estimated to increase from 8.3% in 2013 to double the 
amount around 2030.The WHO has predicted that the major burden will occur 
in developing countries. 
As per the report of international diabetes foundation (IDF), India is 
looming epidemic of diabetes and known as the capital for diabetes. According 
to IDF, India has highest number of, 171 million people suffering from diabetes 
million people suffering from diabetes mellitus, followed by china 56.2million. 
The acute and chronic complication of diabetes is the major cause of 
hospital admission, studies suggested than; Asian clients had more evidence of 
micro and macro vascular complications.  
Data from Chennai based  Rajiv Gandhi  Government General  Hospital  
shows   the diabetes accounts  for of  all lower  extremities  amputations  and  
diabetes  have  a fold higher risk of  requiring  amputations    are compared  to 
their ago   sex matched non-diabetes  controls 10%  of  all  hospital  admission  
is   for diabetic  foot  problem.         
 As per   American  diabetes  association  2010  reports  that  
approximately  10%  of all persons  with diabetes will develop  a  foot  ulcer 
during  the  course  of  their diseases  84%  of  lower  extremely  amputation  
are  proceeded   by  foot  ulcers  of   this   14-24%  will  proceed   to  major  
amputation. 
Complication of Diabetes Mellitus:   
         Acute Complications           Chronic Complications 
 Hyperglycemic Hyperosmolar 
State 
  Diabetic Ketoacidosis 
 Diabetic Coma 
 Micro Vascular Complications 
 Macro Vascular Complications 
 Micro Vascular Complications Macro Vascular Complications 
The Common Micro Vascular  
Complications with its incidence 
related to Diabetes Mellitus includes 
the following, 
¾ Coronary Artery Disease 
¾ Diabetic Neuropathy 
¾ Diabetic Nephropathy 
¾ Diabetic Retinopathy 
The  Common Macro Complications 
with its incidence related to Diabetes 
Mellitus includes the following,  
¾ Stroke 
¾ Peripheral Vascular Disease 
¾ Diabetic Myonecrosis 
Diabetes can affect the feet due to, 
 Neuropathy 
 Peripheral Vascular Disease 
 Infection 
Prevalence of Diabetes (WHO-2014) 
Country In 2000-2014 In 2030
Africa 
America 
Europe 
India 
1,71,000,000-366 Million 
33,016,000-29.1million 
33,332,000-385millon 
31,705,000-171million 
3,66,000,000-552Million 
66,812,000-366millon 
47,973,000-438million 
79,441,000-366million 
Institutional Statistics of Diabetic Mellitus 
Year Inclients Out- clients 
2010 808 20,32,000 
2011 1564 2,40,000 
2012 1703 2,89,000 
2013 1505 2,42,000 
2014 1398 2,01,000 
Diabetic Foot Ulcer                    
Diabetic foot ulcers are the sores that occur on the feet of the people 
with Type 1 and Type 2 diabetes mellitus. Diabetic foot ulcer is defined as 
major erosions of the epithelium that extends into the dermis and deeper tissues 
and is associated with reduced healing capacity (kinmond-2003). The main risk 
factors that causes diabetic foot ulcer are peripheral neuropathy and micro as 
well as macro vascular ischemia. Peripheral neuropathy causes loss of pain or 
feeling into the toes, legs, and arms due to the distal nerve damage and low 
blood flow supply (atherosclerosis), very less oxygen supply, and eventually 
death of tissue in feet occurs. 
Healing stages of diabetic foot ulcers 
 1. More exudating, severely edematous, necrotized wound 
 2. More exudating, edematous, necrotized wound 
 3. More exudating, edematous wound 
 4. Exudating, edematous wound 
 5. Less exudating, less edematous and less epithelialized wound 
 6. More epithelialzed wound 
Diabetic foot ulcer prevalence 
Country Prevalence 
 India 
-South India 
-North India 
 America 
 Africa 
 Iran 
 Kenya 
 Nigeria 
 Nether land 
                              
15% 
14.30% 
10 to 15% 
8.7% 
25 to 29% 
4.6% 
21.2% 
20.4% 
 
Managing diabetic foot ulcer 
There are many way to manage diabetic foot ulcer. Depends upon the 
FRQGLWLRQ RI WKH ZRXQG SDWLHQW¶V DJH IHDVLELOLW\ DQG WKH PHGLFDO IDFLOLWLHV
available the care giver will go for an appropriate type of management for 
diabetic foot ulcer. It includes, 
 Medications(in the form of tablets or insulin injection) 
LSM(Life Style Modifications-dietary modification and exercise)
Following complementary and alternative therapy. 
It can be given singly or as a combination of one or two or all, 
depending upon the Condition and the need of the patient. Among which 
performing or doing the dressing procedure it is the one of the easiest and cost 
effective way of treatment which gives much more advantages for the clients 
while giving management for the diabetic clients. Especially when the patient 
is suffering with foot ulcer performing and doing the dressing procedure with 
yellow myrobalan(Yellow Myrobalan (kadukkai)) powder will help the patient 
to improve the wound healing, anti ulcer activity, and anti inflammatory 
activity to the affected area thus eases the rich of wound healing process.  
Yellow Myrobalan (kadukkai) powder dressing and diabetes 
¾ Its paste with water is found to be anti-inflammatory, analgesic and 
having purifying and healing capacity for wounds. 
¾ Its decotion as a lotion is surgical dressing for healing the wound earlier. 
¾ Anti-bacterial and antioxidant properties 
¾ Wide antibacterial and antifungal activity, esp. against E. coli. 
 The extracts exert an antibacterial effect against salmonella typing, 
salmonella typhimurium, staphylococcus aureus, pseudomonas aeruginosa, 
entero-pathogenic strains of escherichia coli and yersinia enterocolitica, 
which indicates that the extracts of the fruit. 
 
1.1 Need for the study: 
 Diabetes is an important risk for lower extremity arterial disease 
(LEAD).LEAD in diabetes mellitus compound by the presence of peripheral 
vascular disease neuropathy and suspects for infections, Mortality rate is 
increases patient with LEAD, particularly of foot ulceration, or gangrene.                     
The current statistical data shows that 50/1,00,000 of people  suffering 
with diabetes mellitus throughout the world, In India the statistical data shows 
that 62 million of people suffering with diabetes mellitus.    
Infection is one of the most important factors in determining the risk of 
amputation in clients with diabetes. If a standardized treatment is applied with 
a multidisciplinary foot care team, major amputation can be avoided in about 
80%-90% of clients with limb threatening ischemia and in 95% of clients with 
infection. Foot ulceration is the precursor to approximately85%of all diabetic 
amputations and it is estimated that14%-20%of clients with foot ulcers will 
have to undergo amputation infection. Because amputation are related to high 
mortality and morbidity. 
Diabetic foot ulcers are the common and most incidental problem 
among diabetes mellitus. Experts suggest that around 10% of people with 
diabetes develop foot ulcers. Foot ulcers can affect people with Type1 and 
Type2 diabetes. Diabetes influences Foot ulcers in a number of ways, and it is 
important for people with diabetes mellitus to understand the potentially 
several consequences of leaving a foot ulcer untreated. 
Foot ulcers can occur in anyone, and refers to a patch of broken down 
skin usually on the lower leg or feet. When blood sugar levels are high or 
fluctuate regularly skin that would heal normally heal may not properly repair 
itself because of nerve damage. 
Foot ulcer may serious for some people with diabetes, the end result of a 
foot ulcer can be an amputation, less serious foot ulcers can still take a long 
time to heal and be very comfortable this time. 
When I worked in selected ward during my first year m.sc(n) period that 
time I have seen many clients were suffering with diabetic foot ulcer, and 
clients risk factor during that illness period and they were received routine 
medical management, that time I was desired why? We need not to provide 
dressing with traditional medicine, because the traditional medicines are highly 
effective in promoting wound healing activity and it has the fastening effect in 
wound healing. So, now I am going to do the dressing procedure with the help 
of traditional medicine, which is Yellow Myrobalan (Yellow Myrobalan 
(kadukkai)) powder, dressing. 
1.2     Statement of the problem:                               
³A study to assess the effectiveness of Yellow Myrobalan (Kadukkai) 
powder dressing on wound healing in clients with diabetic foot ulcer in selected 
ward, at Rajiv Gandhi Govt. General Hospital, Chennai. 
1.3    Objectives  
 To assess the grading level of diabetic foot ulcer among clients  
 To evaluate the effectiveness of Yellow Myrobalan (Kadukkai) powder 
dressing on wound healing among experimental group as post-test. 
 To compare the wound healing process between experimental and control 
group. 
 To find the association between wound healing process and Yellow 
Myrobalan (Kadukkai) powder dressing with selected demographic 
variable and clinical related variables among experimental group. 
1.4 Operational definitions 
Assessment  refers to the systematically and continuously collect validate  
Information about the diabetic foot ulcer clients.   
 Effectiveness of Yellow Myrobalan (Kadukkai) powder dressing refers to  the 
desired effect in wound healing of diabetic foot ulcer.  
Wound healing is an innate mechanism of action and stepwise repair of lost 
cellular matrix that forms the largest component of the dermal skin layer. 
 Wound infection is a common complication often resulting in delayed 
 wound healing with adverse clinical and financial consequences. 
 Diabetic foot ulcer is a major complication of diabetes mellitus can occur  
  in clients with diabetes. 
 Diabetic mellitus is a pan metabolic, vascular And tri hormonal disorder due 
to insulin deficiency insulin résistance, glucagon excess,  Incretin deficiency 
characterized by chronic hyperglycemia which may lead to acute and chronic 
complications. 
Yellow Myrobalan (kadukkai) powder [or] Chebulic myrobalan used in         
the treatment of foot ulcer. It contains chebulic acid,tannic acid, Gallic acid 
 used for diabetic foot ulcer; this product is a safer herbal remedy for ulcer. 
Traditional century old proven Indian medicine without any side effect or 
reactions, long lasting products, is a non-steroidal and non- systemic anti -
inflammatory action. 
 Powder dressing act as a hygroscopic agent that absorb and retain moisture 
from the air and reduction between skin surfaces and clothing. 
1.5 Assumptions 
 The researcher assumes that, 
¾ Diabetic clients may have inadequate knowledge regarding Yellow 
Myrobalan (Kadukkai) powder dressing. 
¾ Procedure of doing Yellow Myrobalan (Kadukkai) powder dressing 
among clients with diabetic foot ulcer this will promote the wound healing 
process. 
¾ Yellow Myrobalan (Kadukkai) powder dressing may reduce the 
infection, and promotes the wound healing. 
¾ Practice of Yellow Myrobalan (Kadukkai) powder dressing will 
provides the anti diabetic activity, anti ulcer activity, anti fungal activity and 
anti-inflammatory activity 
1.6 Hypothesis 
                H1: There will be a statistically significant difference between 
pre- test and post -test level of grading of wound healing among clients with 
diabetic foot ulcer by doing the procedure of Yellow Myrobalan (Kadukkai) 
powder dressing among clients                   
               H2: There will be a statistically significant association between 
the posttest by level of grading of wound healing after the dressing procedure 
among diabetic foot ulcer clients with selected variables. 
1.7 Delimitations 
9 This study is conducted for a  clients with diabetic foot  
9 ulcer with sample for experimental and control group. 
9 The study period is four weeks. 
9 Clients who got admitted in selected wards at Rajiv Gandhi Government 
General Hospital, Chennai. 
9 Only 60 subjects were taken for study. 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II 
REVIEW OF LITERATURE 
The purpose of the review of literature is to obtain comprehensive 
knowledge bare and in depth information about effectiveness of Yellow 
Myrobalan (Kadukkai) powder dressing on diabetic foot ulcer about wound 
healing process. 
This chapter deals with the selected studies, which are related to 
objectives of the proposed study. 
2.1 Review of related to studies 
2.2 Conceptual frame work 
2.1 Review of related literature 
The research has reviewed the relevant literature in support of problem 
statement of the present study. Literature from 2003 t0 2014 were reviewed. 
The extensive review of literature has been done and it is organized according 
to the following three aspects. 
Part I: Studies Related to Diabetes Mellitus and Diabetic Foot Ulcer 
Part II: Studies Related to Yellow Myrobalan (Kadukkai) Powder  
Part III: Studies related to effectiveness of Yellow Myrobalan (Kadukkai) 
powder on wound healing in clients with diabetic foot ulcer. 
Part I: Literature related to diabetes mellitus and diabetic foot ulcer 
Jeffcoate.w.j. (2003) was conducted a study on ulcer related outcomes 
with diabetic foot disease, city hospital, Nottingham, under cohort study 
method, the study were found to be classified ulcer according to the size, depth 
and sepsis compared with patient related outcomes, in 449patients the results 
emphasize the poor prognosis of lesions managed with only 50.2% of all ulcers 
healing at some stage without amputation within 12 months and another being 
resolved by amputations. 
Nalini Singh, et.al (2005) Prevention of diabetic foot ulcers begins with 
screening for loss of protective sensation, which is best accomplished in the 
primary care setting with a brief history and the Semmes-Weinstein 
monofilament. Specialist clinics may quantify neuropathy with bio thesiometry, 
measure plantar foot pressure, and assess lower extremity vascular status with 
Doppler ultrasound and ankle-brachial blood pressure indices. These 
measurements, in conjunction with other findings from the history and physical 
examination, enable clinicians to stratify clients based on risk and to determine 
the type of intervention. Educating clients about proper foot care and periodic 
foot examinations are effective interventions to prevent ulceration.  
Peggy Souleodegard.et.al(2007)was conducted a study to assess the 
pharmacological therapy Only articles published in English between 1990 and 
May 7, 2007, and including individuals of all ages with type 1 or type 2 
diabetes mellitus were included. Retospective and prospective studies reporting 
adherence to medications using self-report, pill counts, medication possession 
ratios, and electronic monitoring devices were included. Database analyses of 
prescription records from various organizations or countries were included only 
if adherence to pharmacologic therapy was stated. Surveys and questionnaires 
assessing medication taking were also included. The data from the selected 
literature was abstracted independently.  
Mundetx.Pou, et.al (2008) conducted a study to find out the prevalence 
and incidence of chronic complications and mortality in a cohort of type 2 
diabetic clients. The aim of the study was to evaluate the prevalence, incidence 
of micro vascular and macro vascular complications, final events, and mortality 
in type 2 diabetic clients, followed over a period of 10years in spain.The study 
was done in 317 type2 diabetic clients treated at a primary care centre, 
followed for 10years.Variables were described by means of ratio, mean values 
and standard deviation. The chi square test was used to compare ratios and the 
VWXGHQW¶VµWHVWWRFRPSDUHPHDQYDOXHV7KHUHVXOWRIWKHVWXG\VKRZHGWKDWWKH
prevalence of an increase in nephropathy(12%),in retinopathy(6.2%) and in 
neuropathy (2.1%).a decrease in ischemic cardiomyopathy (6.2%),an increase 
in peripheral vascular disease (5.6%).cerebrovascular,events and diabetic foot 
remaining unchanged. The highest incidence rates (1000 subjects/year) were 
nephropathy 43, neuropathy39 and ischemic cardiomyopathy 32.The 
prevalence of cardiovascular risk factors increased over the follow-up; being 
high blood pressure the most noticeable (30%).overall mortality was 28/1000 
subjects/year, being cardiovascular disease the main cause (31.2%).The study 
concluded that the prevalence and incidence of chronic complications and risk 
factors are in Spain. 
Iverson,Marjolin.N.et.al.,(2009)was conducted a study in 
Norway,nord-trondelag health study based on the comparative study method, 
the study were to compare the mortality rates for individuals with and without 
history of diabetic foot ulcer, population based study included 155 diabetes 
mellitus with history of foot ulcer and 1399 diabetes mellitus without history of 
foot ulcer, the study results were 49% of diabetes mellitus individuals with an 
history of foot ulcer, and compared with 35.2%of diabetes mellitus without an 
history of foot ulcer, analyses adjusted for age,sex,education,current smoking, 
and waist circumferences risk of mortality compared with the non diabetic 
group. 
Krishnarajah.G.,(2009) was reported a study on glycaemic variability 
and complications, in patients with diabetes mellitus evidence from a systemic 
review of literature under interventional and observational study group, 
diabetes type-1,diabetes type-2.A study were analyzed totally 18 subjects,8 on 
type-1 diabetes mellitus and 10 were on type-2 diabetes mellitus patients.Type-
1 revealed that glucose variability has little impact on the development of 
diabetic complications, whereas type-2 diabetes mellitus a significant positive 
association between glucose variability and the development of diabetic 
retinopathy, cardiovascular events and mortality was reported in 9of 10 studies. 
Goodridge,Donna,et,al(2009).Foot ulcers are a common, serious, and 
costly complication of diabetes, preceding 84% of lower extremity amputations 
in diabetic clients and increasing the risk of death by 2.4-fold over diabetic 
clients without ulcers. Health-related quality of life (HRQOL) is worse among 
individuals with diabetes than individuals without diabetes, and complications 
of diabetes, including foot ulcers, have a major negative effect on HRQOL. 
Diabetic foot ulcers are associated with reduced mobility and deficits related to 
activities of daily living that adversely affect HRQOL. Qualitative studies have 
confirmed clinical observations that diabetic foot ulcers have a huge negative 
psychological and social effect, including reduction in social activities, 
increased family tensions for clients and their caregivers (spouses or partners), 
limited employment, and financial hardship. Quantitative studies confirm the 
findings of qualitative studies that diabetic foot ulcers exert a negative effect on 
physical functioning, psychological status, and social situation. Recent 
advances include the development and validation of disease-specific HRQOL 
surveys for diabetic clients with foot ulcers. Disease-specific surveys may 
improve the evaluation of HRQOL as a function of ulcer healing, the effect of 
different treatment methods on HRQOL, and the relationship between 
treatment-specific HRQOL, patient compliance, and treatment efficacy. 
Ira B. Lamster (2009) WKHWHUP³GLDEHWHVPHOOLWXV´GHVFULEHVDJURXSRI
disorders characterized by elevated levels of glucose in the blood and 
abnormalities of carbohydrate, fat and protein metabolism. A number of oral 
diseases and disorders have been associated with diabetes mellitus, and 
periodontitis has been identified as a possible risk factor for poor metabolic 
control in subjects with diabetes. Although a number of oral disorders have 
been associated with diabetes mellitus, the data support the fact that 
periodontitis is a complication of diabetes. Clients with long-standing, poorly 
controlled diabetes are at risk of developing oral candidiasis, and the evidence 
indicates that periodontitis is a risk factor for poor glycemic control and the 
development of other clinical complications of diabetes. Evidence suggests that 
periodontal changes are the first clinical manifestation of diabetes.Diabetes is 
an important health care problem. The evidence suggests that oral health care 
providers can have a significant, positive effect on the oral and general health 
of clients with diabetes mellitus. 
SueE.Gardner,et, al (2010) the identification and diagnosis of diabetic 
foot ulcer (DFU) infections remains a complex problem. Because inflammatory 
responses to microbial invasion may be diminished in persons with diabetes, 
clinical signs of infection are often absent in persons with DFUs when infection 
is limited to localized tissue. In the absence of these clinical signs, microbial 
load is believed to be the best indicator of infection. Some researchers, 
however, believe microbial load to be insignificant and type of organism 
growing in the ulcer to be most important. Previous studies on the 
microbiology of DFUs have not provided enough evidence to determine the 
microbiological parameters of importance. Infection-related complications of 
DFUs include wound deterioration, osteomyelitis, and amputation. Risk factors 
for amputation include age, peripheral vascular disease, low transcutaneous 
oxygen, smoking, and poor glycaemic control.These risk factors are best 
measured directly with physiological measures of arterial perfusion, glycemic 
control, sensory neuropathy, plantar pressures, and activity level and by 
controlling off-loading,diabetic foot ulcer  disburden has not been examined as 
a risk factor for infection-related complications.  
Part II: Studies Related to Yellow Myrobalan (kadukkai) Powder  
Kiranmande,et,al (2010)Haritaki- Means one which is originated from 
Hari's (God's) home or Which is green in nature; here green stands for faith and 
fertility. Or that carries away all the illnesses from the body. It is said that when 
Indra (king of deities in Hindu mythology) was drinking nectar in heaven, a 
drop of the fluid fell on the earth and produced Haritaki. Haritaki is also used 
as a purgative in ayurvedic treatments. It is also used as a tonic and 
expectorant. Haritaki is also known to process strong anti-mutagenic 
properties. Haritaki is used in the treatment of mouth ulcers, stomatitis, asthma, 
cough, candidiasis, gastroenteritis, skin diseases, and leprosy act. It is also used 
for treatment of intermittent fever, rheumatic pain and fever, wounds and 
arthritis. Haritaki is one of the best herbs for treatment of Vatadosha. It is used 
as a natural remedy for Vata disturbances like flatulence, indigestion ect. 
Haritaki is contradicted in person with weak digestion and also in pregnancy. 
Haritaki is also believed to improve intelligence and alertness in a person.  
Reetu Ahirwar, (2011) was  explained haritaki in her own way. There 
is six type of Haritaki :-Vijaya, Rohini, Putana, Amrita, Abhya, Jeewanti and 
Cheataki. Also there is three more division: - small Haritaki, big Haritaki and 
yellow Haritaki. Action of Haritaki:-Vijaya works at all types of diseases. 
Haritaki is useful in vitiation of all the three humors. It is better esp. in Vata 
disorders. Its paste with water is found to be anti-inflammatory, analgesic and 
having purifying and healing capacity for wounds. Its decoction as a lotion is 
surgical dressing for healing the wound earlier. Equal parts of three myrobalan 
and catechu are made in a paste with clarified butter or some bland oil work as 
an ointment in chronic ulcerations, ulcerated wounds and other skin diseases 
with discharge. These ointments could be a substitute for Gall ointments used 
in Britain.  
Ammas, et al (2011) Terminalia was found to have anti-diabetic 
activity. The extracts of Terminlia for its anti-hypoglycemic and anti-diabetic 
activity was conducted against the advanced glycation end products (AGEs)-
induced endothelial cell dysfunction and was found out that the treatment of 
chebulic acid reduced glycer-AGE induced formation. The methanolic and 
ethanolic extracts of the plant was found to reduce the glucose level.Anti-
inflammatory activity was expected to be present in terminalia chebula and was 
tested in the Swiss albino mice. Triphala treatment was found to significantly 
inhibit the paw volume and also the levels of lysosomal enzymes, lipid per 
oxidation and inflammatory mediator tumour necrosis factor. However the anti-
oxidant status was found to show an increase in the plasma, liver and spleen of 
monosodium urate crystal-induced mice on comparison with the control mice. 
ß-glucuronidase and lactate dehydrogenase level were also found to be reduced 
in Triphala treated monosodium urate crystal-incubated polymorpho nuclear 
leucocytes. Results obtained from the above studies clearly indicated that 
Triphala possess a strong anti-inflammatory effect against gouty arthritis. 
R Rathinamoorthy et al., (2012) Reported as the study was focused on 
treatment of water and methanol extracts of Terminalia chebula fruits and citric 
acid as a cross linking agent on cotton plain-woven fabric. The active 
antimicrobial compounds in extracts were analyzed by high performance liquid 
chromatography. The fabric samples were tested for antibacterial activity 
against bacterial Staphylococcus aureus, Escherichia coli, Klebsiella 
pneumoniae, Proteus vulgaris, and Salmonella typhi under agar diffusion 
strains like test and quantitative analysis. The treated samples showed 99% of 
reduction against Staphylococcus aureus and 86.25% reduction against 
Escherichia coli as per quantitative analysis.. Process parameters were 
optimized using the response surface methodology adopted using Box Behnken 
design and the correlation coefficient was found to be 0.932 in the case of 
Staphylococcus aureus and 0.66 in the case of Escherichia coli. 
Mande (2012) Haritaki has laxative, rejuvenative, purgative, astringent 
and dry properties. The paste of its fruit is effective in reducing swelling, 
hastening the healing process and cleansing the wounds and ulcers. The paste 
gives relief to the eyelids, in case of conjunctivitis. Gargling with haritaki 
decoction helps in stomatitis, oral ulcers and sore throat. It serves as a good 
astringent for loose gums, bleeding and ulceration in gums. In a paste form it 
can also be used to heal wounds and chronic ulcers. Haritaki is also available in 
powder form. The powder of this fruit is brownish in color and is shown in 
figure 5.The observation under microscope shows a few fibers, vessels with 
simple pits and groups of sclerosis. The hydro alcoholic extract of T.chebula 
fruit was tested for its wound healing activity in the alloxan induced diabetic 
rats by using the excision and dead space wound models which showed a 
significant increase in the wound healing activity in the fruit extract treated 
rats. The Terminalia chebula extract was found top remote the healing of 
wound contraction in alloxan induced diabetic rats when applied topically by 
means of increasing the rate and extent of wound closure. The wound healing 
activity of the ethanol extract of fruit of Terminalia chebula was also evaluated 
on excision and incision model in the albino rats in the form of an ointment. 
DollySingh, Deepthi Singh, et.al, (2014) was conducted a study 
yeungnam university,korea.The study was focused on the traditional medicines 
used in the treatment of wound healing, the terminalia chebula (Kadukkai) 
extracts where found to reducing toxic effect and to increasing higher cellular 
activity proven under live dead-assay and phalloiden/cytokeratin staining 
method, and it is found to be used as a bioactive compound for wound healing 
without affecting normal cellular matrix. 
PART III:Studies related to effectiveness of Yellow Myrobalan 
(Kadukkai) powder on wound healing in clients with diabetic foot ulcer. 
Vimala G et al., (2010) was conducted a study on anti ulcer activity, in 
ayurvedic Terminalia chebula (combretaceae) is commonly known 
DV¶¶P\UREDODn, it is locally called Yellow Myrobalan (Kadukkai).This drug 
available in powder form also make an excellent paste as an application for 
FKURQLF XOFHUDWLRQV DQG XOFHUDWHG ZRXQGV DQG LW DOVR FDOOHG DV µNLQJ RI
mHGLFLQH¶ EHFDXVH RI  LWV H[WUDRUGLQDU\ SRZHU RI ZRXQG KHDOLQJ 7KLV
medicine has been demonstrated to possess multiple pharmacological and 
medicinal activities such as anti diabetic; anti-inflammatory and wound healing 
activity and also Antibacterial activity of Terminalia chebula extracts against 
several bacterial strains have been reported.  
Kunli,yenpeng diao,et,al.,(2011)was conducted a study on terminalia 
chebula (yellow myrobalan) extracts promote the cutaneous wound healing the 
study was done in rats by casein method. The extracts of terminalia chebula is 
an effective components in promoting the process of wound healing, after 
optimal extraction and purification of tannin extracts was increased 81%,the 
tannin extract showed the inhibition of staphylococcus aureus and klebsiella 
pneumonia in vitro,after excision of wounds, divided into group-1,and group-
2,in 10 consecutive days,group-1 was taken tannin extracts medicine ,the 
wound healing quality of group-1 was found to be better than group-2.  
Hong Yang et,al (2011) Conducted a study on Tannins extracted from 
immature fruits of terminalia chebula fructus retz. Are considered as effective 
components promoting the process of wound healing. The objective of this 
study is to explore the optimal extraction and purification technology (OEPT) 
of tannins, while studying the use of this drug in the treatment of a cutaneous 
wound as well as its antibacterial effects. The content of tannin extracts was 
measured by the casein method, and antibacterial ability was studied by the 
micro-dilution method in vitro. In wound healing experiment, group I, II and 
III were treated with Vaseline ointment, tannin extracts (tannin content: 81%) 
and erythromycin ointment, respectively (5 mg of ointment were applied on 
each wound). To evaluate the process of wound healing, selected 
pharmacological and biochemical parameters were applied. After optimal 
extraction and purification, content of tannin extracts was increased to 81%. 
Tannin extracts showed the inhibition of staphylococcus aureus  and 
klebsiella pneumonia in vitro. After excision of wounds, on days 7 and 10, the 
percent of wound contraction of group II was higher than that of group I. After 
being hurt with wounds, on days 3, 7, and 10, the wound healing quality of 
group II was found to be better than that of group I in terms of granulation 
formation and collagen organization. After wound creation, on day 3, the 
vascular endothelial growth factor expression of group II was higher than that 
of group I. 
Pradeep Bhat, Ganesh R.Hedge, et.al.,(2012),was conducted the study 
in biodiversity hotspots, in Karnataka state of india,regarding documentation 
analysis of ethanomedicinal plants in the treatment of wounds, collection of 
information through semi-structured open ended interviews with a 
questionnaire, recording 106 medicinal plant species of 55 families and 86 
formulations to treat different types of wound treated by traditional healers and 
they found 106 plants in traditional practices for curing various type of 
wounds. The statistical analysis confirmed high degree of wound healing in 
traditional medicinal practices. 
Aruna S et al., (2014) was conducted a study the demand for herbal 
therapeutics is increasing gradually in the world. The Indian system of 
medicines uses herbal preparations in majority for the management of diseases. 
Globally a large number of Pharmacological studies have been conducted 
extensively on various medicinal plants. In recent years a lot of research is 
being conducted on terminalia chebula (Haritaki). The pharmacological studies 
of Haritaki (or) Terminalia chebula, herbal drugs,in Indian medicinal plants.  
Thilagavathy G (2014) Said that ,many Indian plants have been used 
from time immemorial to treat various diseases and infections in traditional 
medicinal systems It is a medicinal plant widely distributed throughout India, 
Burma, and Srilanka.Terminalia chebula is one of the most commonly used 
plants in traditional systems of medicine in Indian sub-continent. Terminalia 
FKHEXODLVFDOOHGWKHµ.LQJRI0HGLFLQH¶LQ7LEHWDQGLVDOZD\VOLVWHGDWWKHWRS
of the list in Ayurvedic Materia Medica due to its extraordinary power of 
healing.. Terminalia chebula, 33% of the total phytoconstituents are 
hydrolysable tannins (which may vary from 20-50%) and are responsible for 
pharmacological activity. These tannins contain phenolic carboxylic acid like 
gallicacid, ellagic acid, chebulic acid and gallotannin acid. 
PoojaAgrahari et al (2014) was conducted a study of   
Terminaliachebula (Combretaceae) is also FDOOHG WKH ³.LQJ RI PHGLFLQHV´ LQ
Tibet and is always listed first in the Ayurvedic material medica because of its 
extraordinary powers of healing with a wide spectrum of biological activity. A 
number of chemical constituents have been isolated from the plant extract that 
include chebulin, ellagic acid, 2,4-chebulyl-D-glucopyranose, arjunglucoside I, 
arjungenin, chebulinic acid, Gallic acid, ethyl gallate, punicalagin, terflavin A, 
terchebin, luteolin and tannic acid. The plant is an important constituent of an 
herbal formulation, contains the name TRIPHALA which is very popular 
traditional medicine for chronic disorder like diabetes.  
2.2 Conceptual frame work            
0RGLILHG2UHP¶V7KHRU\RI6HOI&DUH'eficit                    
The conceptual framework of the present study as depicted in the 
GLDJUDPZDVGHYHORSHG RQ WKHEDVLV RI2UHP¶V WKHRU\ RI VHOI FDUH6HOI FDUH
deficit theory or nursing is composed of six basic concepts and one related or 
peripheral concept. The basic or core concepts are self-care, self care agency, 
therapeutic self care demand, self care deficit, nursing agency and nursing 
system. 
 Self care (dependent care) 
The practice of activities that individuals, initiate and perform on their 
own behalf in maintaining life, health and well being (1991).In this study the 
diabetic clients with foot ulcer will acquire demand or requirements to sustain 
and maintain life called as health deviated self care requirement i.e., ignorance 
of care of foot ulcer. 
 Self care agency (dependent care agency) 
Self care agency is the power of individuals to engage in self care and 
the capability for self care. The person who uses the power or self care ability 
in the self care agent. In this study the self care agency is the clients with 
diabetic foot ulcer. 
 Therapeutic self care demand 
,WFDQEHWKRXJKWRIDVDFROOHFWLRQRIDFWLRQWREHSHUIRUPHGRUµ¶D
SURJUDPPHRIDFWLRQ¶¶7KLVWRWDOLW\of care action is performed to meet the self 
care requisites. In this study, the therapeutic self care demand is the need for 
information, education, communication and demonstration regarding Yellow 
Myrobalan (kadukkai) powder dressing to promote wound healing process. 
 Self care deficit 
 A self care deficit is the relationship between self care demands of the 
individuals in which capabilities for self care are not equal to meeting some or 
all of the components of their therapeutic self care demands. In this study the 
self care deficit is the inadequate care to promote wound healing process. 
 Nursing agency 
In this study the investigator is the nursing agency carries out the 
information on wound healing of the diabetic foot ulcer in selected wards, at 
Rajiv Gandhi Government General Hospital, Chennai. Where the pre 
assessment of the wound was done and the frequent regular interval the post 
assessment also was carried out on wound healing. 
 Nursing system 
All the actions and the interactions of the nurses and clients in nursing 
practice situation. There are three types of nursing systems, i.e., wholly 
compensatory, practically compensatory and supportive educative system. In 
this study the investigator has chosen the supportive educative system as 
nursing system in which demonstration of performing Yellow Myrobalan 
(Kadukkai) powder dressing was explained in a structured manner with the 
help of flash cards and administered to the clients of those who are having 
diabetic foot ulcer. 
STEP-1: Identification of a need for help 
Identification involves individualization of the diabetic subjects, his/her 
H[SHULHQFHVDQGUHFRJQLWLRQRIWKHVXEMHFW¶VSHUFHSWLRQRIKLVFRQGLWLRQ,QWKLV
study the investigator identifies the demographic variables, medical related 
information and assessment of wound using Wagner wound assessment scale. 
The central purpose is to promote wound healing process effectively. 
STEP-2: Ministration of help 
Ministration is providing the needed help. It requires the identification 
of the need for help, the selection of a helping measure appropriate to that need, 
and the acceptability by the patient. Yellow Myrobalan (kadukkai) powder 
dressing was provided to subjects with diabetic foot ulcer to promote wound 
healing process. 
 
STEP-3: Validation that need for help was met 
Validation is evidenced that the diabetic foot ulcer subjects with 
functional ability will be restored as a result of the help given. It is validating 
that the needed help was delivered in achieving the central purpose. The step 
involves the post assessment after ministering the help analysis to make 
suitable decision and recommended action either to continue or modify the 
nursing action. 
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CHAPTER - III 
RESEARCH METHODOLOGY 
This chapter deals with methodology which was adopted for the study and 
includes the description of research approach, research design, variables ,setting of 
the study population, sample size and sampling techniques, criteria for sample 
selection, development and description of tool, data collection procedure and plan 
for data analysis. 
3.1 Research Approach 
In this study the quantitative research approach was used, the investigation 
aims at evaluating the effectiveness of practicing Yellow Myrobalan (Kadukkai) 
powder dressing among diabetic foot ulcer clients to study the effectiveness of 
wound healing process, it also helps the researcher with the suggestions of 
possible conclusions to be drawn from the data. 
3.2 Duration of the study: 
Four weeks (from 15.07.2015 to 14.08.2015) 
3.3 StudySetting: The study was conducted in selected wards at Rajiv Gandhi 
Government General Hospital Chennai. It is one of the biggest hospitals in south 
Asia. This hospital consists of the medical, surgical and nursing specialties and 
super specialties, it is an educational research institute as well as referral hospital. 
The total bed strength of this hospital is 3000. 
3.4 Study Design: Is the structural framework for the study implementation and 
it is true print of the study (Talbot, 1995). In the present study, true experimental 
research (pre test- post test only) design was adopted, the overall plan for 
collecting and analyzing data including specification for enhancing the internal 
and external validity of the tool. 
 
 
 
 
 
 
Fig-3.1 Schematic Diagram of study design 
3.5. Study population is the subjects and events potentially available for the 
research study. In this study, the population includes the clients with Diabetic 
Mellitus with foot ulcer admitted at Rajiv Gandhi Government General Hospital, 
Chennai.  
3.6 Sample Size 
The sample size for this study was 60  
                 (Experimental group±30 and Control group-30) 
3.7 Sampling criterian 
3.7.1 Inclusion criteria 
  Clients with diabetic foot ulcer in the age group of 40 and above. 
  Clients who are available in selected wards during the data collection 
              Period. 
  Clients who are willing to give consent for the procedure of doing 
   Yellow Myrobalan (Kadukkai) powder dressing. 
 Clients who are able to speak and understand Tamil and English language. 
Experimental 
Group Pretest 
Intervention 
Yellow Myrobalan 
(Kadukkai) powder 
Posttest 
Random 
Assignment 
Control 
Group Pretest 
Posttest Routine 
management  
3.7.2 Exclusion criteria. 
 Clients with history of allergy to (Yellow Myrobalan (Kadukkai)) yellow 
myrobalan powder dressing. 
 Clients with other associated problems like gangrene in the foot. 
3.8 Sampling technique: 
Study samples were collected by method of simple random sampling 
technique, selected samples were divided as two groups by selecting odd numbers 
and even numbers, odd numbers were allotted for experimental group and even 
numbers were allotted as control group and who fulfilled the inclusion criteria, 
were included in the study.  
3.9 Research variables 
                     The categories of variables discussed in this study were, 
 Independent variable: 
                            Yellow Myrobalan (Kadukkai) powder dressing. 
 Dependent variable:  
                             Diabetic foot ulcer.  
3.10 Development and description of the tool  
3.10.1 Development of the tool 
Appropriate tool was selected with the help of review of literature from the text 
book, internet search and discussion with H[SHUW¶V opinion of medical, nursing and 
statistician the tool was prepared. 
3.10.2 Description of the tool 
Section A: Consist of Demographic variables (Age, Sex, Occupation, Income, 
educational status, marital status and type of family) 
Section B: Consist of clinical related information (Diagnosis, duration of illness, 
type of treatment, type of medication used and type of diet). 
Section C: Wagner Wound Assessment Scale. 
Section D: Healing Stages of Diabetic Foot Ulcers 
Scoring key 
Wagner Wound Assessment Scale. 
1 - Intact Skin Score 0 
2- Superficial ulcer of skin or subcutaneous tissue Score 1 
3 - Ulcers extend into tendon, bone, or capsule Score 2 
4 - Deep ulcer with osteomyelitis, or abscess Score 3 
5 -Gangrene of toes or forefoot Score 4 
6 - Midfoot or hind foot gangrene Score 5 
 
* High score indicates the severity of diabetic foot ulcer. 
* Low score indicates the healthy. 
Healing stages of diabetic foot ulcers 
1. More exudation, severely edematous, necrotized wound 
2. More exudation, edematous, necrotized wound 
 3.More exudation, edematous wound 
4. Exudation, edematous wound 
5. Less exudation, less edematous and less epithelialized wound 
6. More epithelialzed wound 
3.10.3 Intervention Protocol 
S.No Protocol Experimental group  Control group 
1. Place    Rajiv Gandhi Government   
General           Hospital, 
Chennai. 
(Selected wards) 
Rajiv Gandhi 
Government General    
Hospital, Chennai. 
(Selected wards) 
2. Recipient Clients with diabetic foot 
ulcer 
Clients with diabetic 
foot ulcer 
3. Intervention  Yellow Myrobalan 
(Kadukkai) powder 
dressing 
Routine dressing 
care. 
4. Dose  20grams of Yellow 
Myrobalan (Kadukkai) 
powder for each dressing. 
        ---------- 
5. Duration  21days 21days 
6. Frequency  Daily dressing Daily dressing 
7 Time  7.30am to 4.00pm 7.30am to 4.00pm 
8 Administered by The investigator The investigator 
3.10.4 Content validity 
The experts validated the relevance, sequence, adequacy of language of the 
tool. Validity of the tool was assessed using content validity. They suggested 
certain modifications in tool. After the modifications they agreed this  tool for 
evaluate the effectiveness  of Yellow Myrobalan (Kadukkai) powder  dressing  on  
wound  healing  in clients  with  diabetic  foot  ulcer  in  selected  wards, at  Rajiv 
Gandhi  Government. General Hospital,Chennai. 
 
3.11 Ethical consideration 
The study proposal tool, objective, intervention and data collection 
procedure were approved by the research and the Institutional ethics committee, 
Madras Medical College, Chennai. Permission was obtained from the professor 
and Head of the Department, Institute of Diabetology and the professor and Head 
of the Department, Institute of General Surgery, Rajiv Gandhi Government 
General Hospital, and Chennai, all subjects were carefully informed about the 
purpose of the study. Ensured confidentiality of the study result. The freedom was 
given to the client to leave the study at his/her will without assigning any reason. 
No routine care was altered or withheld. The investigator followed the ethical 
guidelines which were issued by the research committee, written consent was 
obtained from all subjects. 
3.12 Pilot study 
Formal permission was obtained from the concerned higher authorities at 
Rajiv Gandhi Government General Hospital, Chennai. The pilot study was 
conducted in selected wards at Rajiv Gandhi Government General Hospital, 
Chennai. Samples were selected with the help of Wagner Wound Assessment 
Scale within the range of 0-5 among 10 samples, 5 samples were in experimental 
group and 5 samples were in control group. Informed consent was obtained from 
the subjects. Yellow Myrobalan (Kadukkai) powder dressing was performed for 
experimental group and routine care was provided for the control group.Pre and 
post- assessment of the wound was done to study the wound healing process by 
using wound assessment scale for both the group. The data were analyzed and the 
result of the study revealed that, it was highly effective of doing Yellow 
Myrobalan (Kadukkai) powder dressing, Study was practically feasible, and this 
medicine was found reliable for proceeding with the main study. 
 
3.13 Reliability 
After pilot study reliability of the tool was assessed by using Simple 
random technique interrater method and its correlation coefficient r ±value was 
0.81. This correlation coefficient is very  high and it is  good tool for evaluate the 
effectiveness of Yellow Myrobalan (Kadukkai) powder  dressing  on  wound  
healing  in clients  with  diabetic  foot  ulcer  in  selected  wards, at  Rajiv Gandhi  
Government General Hospital, Chennai. 
3.14 Data collection procedure  
A formal written permission was obtained from the professor and Head of 
the Department, Institute of diabetology and the professor and Head of the 
Department, Institute of General Surgery, at Rajiv Gandhi Government General 
Hospital, Chennai.  
          Study samples were collected by method of simple random sampling 
technique, selected samples were divided as two groups by selecting odd numbers 
and even numbers, odd numbers were allotted for experimental group and even 
numbers were allotted as control group and who fulfilled the inclusion criteria, 
were included in the study.  
           The subjects for the study were selected based on the Wagner Wound 
Assessment Scale within the grade of 0-5. The study purpose and method were 
explained to all subjects and informed written consent was obtained. 
Confidentiality was assured to all the subjects. The information regarding 
demographic profile and medical related information were collected from 60 
diabetic subjects by interviewing them and observing health records. 30 subjects 
were included for experimental and 30 subjects were included for control group. 
Routine care was not altered. 
 
Phase-1 
The pre assessment of the wound was done with the help of Wagner 
Wound Assessment Scale for all subjects and it was recorded on the first day of 
the study.  
Phase-2 
Preparation of powder paste 
 1packet =100grams of Yellow Myrobalan (Kadukkai) powder. 
 20grams of Kadukkai powder. 
 10ml or 20ml of distilled or sterile water to make paste. 
 Purposes of yellow myrobalan (Kadukkai) powder 
 To improve wound healing status. 
 To reduce the wound exudates. 
 To improve blood circulation. 
 To reduce the inflammation. 
 To cleansing the wound and ulcer. 
 To improve fastening the healing process. 
              About Yellow Myrobalan (Kadukkai) powder dressing was explained to 
the diabetic foot ulcer subjects, and the subjects were helped to do Yellow 
Myrobalan (Kadukkai) powder dressing with the help of distilled water. The same 
procedures were followed for all the subjects for a period of 21days and 
periodically assess the healing stages of diabetic foot ulcer by wound assessment 
scale done daily. The control group subjects were treated with routine dressing 
management.  
Phase-3 At the22nd day the investigator assessed the wound healing process after 
the intervention with the help of Wagner Wound Healing Assessment Scale for 
both experimental and control group to evaluate the effectiveness of Yellow 
Myrobalan (Kadukkai) powder dressing. 
3.15 Data entry and Data analysis 
Time taken for each patient for the procedure, data was collected and 
analyzed in terms of the objectives of the study using descriptive and inferential 
statistics. 
Descriptive statistics include 
1) Mean, standard deviation, frequency and percentage describe the 
demographic profile and clinical related information of diabetic foot ulcer clients. 
Inferential statistics include 
3DLUHGµW¶WHVWWRDVVHVVWKHHIIHFWLYHQHVVRI<HOORZ0\UREDODQ.DGXNNDL 
     Powder dressing on wound healing process in experimental groups. 
2) Chi±square test to associate between the selected demographic variables 
     and clinical related variables. 
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Research design: true experimental study 
Setting of the study: in selected wards at rajiv gandhi 
government general hospital, chennai - 03 
Sampling technique: simple random technique 
Experimental group Control group 
Pre-assessment-assessing the condition of the diabetic foot 
ulcer using wagner wound assessment scale 
 Yellow Myrobalan (Kadukkai) 
Powder dressing Routine care 
Post assessment- assessing the condition of the diabetic foot 
ulcer using wagner wound assessment scale 
Comparison of pre and post assessment 
Analysis and interpretation of findings 
Dissemination of findings and recommendation
Study population: clients with diabetic foot ulcer
CHAPTER IV 
DATA ANALYSIS AND INTERPRETATION 
               This chapter deals with analysis and interpretation of data collected from 
60 diabetic foot ulcer clients admitted in selected wards, at Rajiv Gandhi 
Government General Hospital, Chennai. Statistical procedure enabled the 
researcher to deduce, summarize, organize, evaluate, interpret and communicate 
the numeric information in a meaningful and intelligible way.Analysis and 
interpretation of the data were based on collection of the data through Simple 
Random Technique. Descriptive and inferential statistics were used for the 
analysis of the data. Data were tabulated and presented according to the objectives. 
4.1 Organization of the data 
Section I  
           Distribution of demographic variables of diabetic foot ulcer clients   
Section II  
           Distribution of clinical variables of diabetic foot ulcer clients. 
Section III  
           Distribution of grading level of diabetic foot ulcer among clients in  
experimental and control group. 
Section IV- 
          Distribution of effectiveness of Yellow Myrobalan(Kadukkai) powder dressing 
on diabetic foot ulcer among experimental and control group. 
Section V 
           Distribution of comparison of wound healing process between           
Experimental and control group. 
 
Section VI    
                    Distribution of post-assessment of wound healing process in clients  
                    with diabetic foot ulcer in experimental and control group. 
Section VII   
                     Distribution of association between wound healing process and 
                     Yellow Myrobalan (Kadukkai) powder dressing with selected 
                     Demographic variables and clinical related variables among  
                     Experimental group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section ±I: Distribution on demographic variables of clients with 
diabetic foot ulcer 
Table 4.1: Demographic profile: Frequency and percentage distribution of 
subjects in the experimental and control group regarding their back ground factors 
of clients with diabetic foot ulcer.  
S.NO 
Demographic variables 
  
group Chi square  
Experiment Control 
f % f % 
1. Age 
  
  
  
40 -49 years 9 30.0 15 50.0 2=2.78  
p=0.42 
 
 
50 -59 years 13 43.3 8 26.6 
60 -69 years 6 20.0 5 16.7 
\HDUV 2 6.7 2 6.7 
2. Gender 
  
Male 22 73.3 16 53.3 2=2.58  
p=0.10 Female 8 26.7 14 46.7 
3. Marital Status 
  
  
  
Married 20 66.7 22 73.3 2=1.09  
p=0.77 
 
 
Unmarried 2 6.7 1 3.3 
Divorced/Separated 1 3.3 2 6.7 
Widower/Widow 7 23.3 5 16.7 
4. Religion 
  
  
Hindu 23 76.7 20 66.6 2=1.74  
p=0.48 
 
Christian 4 13.3 8 26.7 
Muslim 3 10.0 2 6.7 
5. Type of Family 
  
  
Nuclear Family 12 40.0 14 46.7 2=0.51 
p=0.77 
  
Joint Family 16 53.3 15 50.0 
Broken Family 2 6.7 1 3.3 
6. Educational Status 
  
  
  
illiterate 8 26.7 6 20.0 2=3.33  
p=0.34 
 
Elementary 
18 60.0 15 50.0 
Higher Secondary 2 6.7 7 23.3 
Graduate and above 2 6.7 2 6.7 
7. Occupation 
  
  
  
  
House Wife 2 6.7 2 6.7 2=3.46  
p=0.48 
           
Government 4 13.3 6 20.0 
Private 14 46.7 17 56.7 
Pensioner 5 16.7 4 13.3 
Unemployed 5 16.7 1 3.3 
8.  Family monthly Income 
  
  
  
< Rs.3000 5 16.7 5 16.7 2=2.24  
p=0.52 
  
Rs.3001-5000 7 23.3 3 10.0 
Rs.5001-8000 12 40.0 13 43.3 
> Rs.8001 6 20.0 9 30.0 
9. Area of Residence 
  
Rural 11 36.7 12 40.0 2=0.07  
p=0.77  Urban 19 63.3 18 60.0 
10. Dietary Pattern 
  
  
Vegetarian 9 30.0 8 26.7 2=1.52  
p=0.47 Non-Vegetarian 6 20.0 3 10.0 
Mixed Diet 15 50.0 19 63.3 
                
             The table shows the distribution of subjects in demographic variables of 
clients with diabetic foot ulcer. 
  Age distribution, the study participants in experimental group 30.0% (9) were 
belongs to the age group 40-49 years and control group 50% (15), age group 
between 50-59 years in experimental group 43.3%(13) and control group 
26.6%(8),age group 60-69years in experimental group 20.0%(6) and control group 
16.7% (5) and age group 7o and above 70years in experimental group 6.7%(2) and 
in control group 6.7%(2). 
Gender distribution regarding the gender distribution subjects was male 
73.3 %(22) in experimental group and in control group 53.3% (22) and female was 
26.7 %( 8) and control group 46.7 % (14). 
Marital status, higher numbers of married subjects participated in this study 
66.7% (20) Experimental and 73.3% (22) Control group. Unmarried subjects 
6.7%(2)in experimental group and in control group 3.3% (1),divorced/separated 
subjects were in experimental group 3.3% (1) and in control group 6.7%(2) and 
Widower/Widow subjects were in experimental group 23.3%(7)and in control 
group 16.7% (5). 
 Religion subjects were mainly Hindus in the76.7 %( 23)experimental group and 
control group 66.6%(20),Christian 13.3%(4)experimental group and control 
group26.7%(8)and Muslim subjects were in experimental group 10.0%(3) and in 
control group 6.7% (2). 
 Type of family, regarding Type of family subjects in experimental grand control 
oup40.0%(12) and in control group 46.7% (14) and 53.3%(16) and control group 
50.0% (15) belongs to joint family and broken family subjects were 6.7% (2) in 
control group 3.3% (1). 
Educational status, majority of them were educated up to illiterate level in 
experimental group 26.7%(8) and control group 20.0%(6),elementary subject 
were60%(18) experimental and 50 %( 15) control group, higher secondary 
subjects were 6.7% (2) and control group 23.3% (7) and graduate and above 
subjects were 6.7%(2) in experimental group and in control group 6.7%(2). 
Occupation regarding house wife Subjects were in Experimental group 6.7% (2) 
control group 6.7%(2), government subjects were in experimental group 13.3% (4) 
and control group 20.0%(6), 46.7% (14) and control group 56.7 % (17) members 
were working in private concerns, pensioner subjects were 16.7%(5)and control 
group 13.3%(4) and unemployed subjects were 16.7% (5) and in control group  
3.3%(1). 
Income, almost all the study participants were belongs to low socio economic 
status among that around <Rs.3000 in experimental  and control group 16.7% 
(5),Rs.3001-5000 in experimental group 23.3% (7) and control group 10.0% 
(3),Rs.5001-8000 in experimental group 40% (12) in control group 43.3% (13) 
and >Rs.8001 subjects were in experimental group 20.0% (6) and in control group 
30.0% (9). 
Area of residence, subjects were from urban in experimental group 63.3 %( 19) 
control group 60%(18) and rural area of residence in experimental group 36.7% 
(11) and in control group 40.0% (12). 
Dietary pattern, regarding vegetarian subjects were in experimental group 30.0% 
(9) and control group 26.7% (8),Non-vegetarian subjects were in experimental 
group 20.0% (60) and control group 10.0% (3) and 50%(15) in experimental group 
and in control group 63.3% (19) members were following mixed group dietary 
pattern. 
 
Section±II: Distribution on clinical related variables of clients with  diabetic 
foot ulcer 
Table 4.2: Clinical related variables  
s.no 
 Clinical   related  variables 
  
             Group 
Chi square test Experiment Control 
F  % F  % 
1. Type of Diet CHO Rich Diet 1 3.3 1 3.3 2=0.00 
p=1.00 
 
Mixed Diet 29 96.7 29 96.7 
2. H/o. Ch. 
Illness 
  
Yes 22 73.3 25 83.3 2=0.88 
 p=0.34 
 No 8 26.7 5 16.7 
3. 
If yes, Specify 
 
 
 
 
  
Nil 8 26.7 5 16.7 2=1.66  
p=0.78 
 
                          
 
 
                    
Hypertension 14 46.7 15 50.0 
Cardiovascular problems 4 13.3 6 20.0 
Chronic Kidney Disease 3 10.0 2 6.7 
Neurological Problems 1 3.3 2 6.7 
4. H/o. Any 
Medication for 
Chronic Illness 
Yes 22 73.3 25 83.3 2=0.88  
p=0.35 No 8 26.7 5 16.7 
5. Duration of 
Illness 
  
  
  
1-2 Years 13 43.3 18 60.0 
2=2.20  
p=0.53 
 
2-5 Years 11 36.7 9 30.0 
5-10 Years 3 10.0 2 6.7 
>10 Years 3 10.0 1 3.3 
6. 
Duration 
Under Diabetic 
Medication 
< 2Years 13 43.3 19 63.3 
2=3.01 
 p=0.53 
2 - 5 Years 10 33.4 8 26.7 
5 -10Years 4 13.3 2 6.7 
>10 Years 3 10.0 1 3.3 
7. 
Type of 
Medication 
  
  
  
Diet and Medication 2 6.7 1 3.3 
2=4.42  
p=0.22 
 
OHA-Oral Hypoglycaemic 
Agent 3 10.0 1 3.3 
Insulin 19 63.3 26 86.7 
Insulin and Oral 
Hypoglycaemic Agent 6 20.0 2 6.7 
8. Grade of 
D/F/U 
  
  
  
Grade -1 13 43.3 10 33.3 
2=2.51 
 p=0.47 
 
Grade -2 12 40.0 07 23.3 
Grade -3 05 16.7 08 26.7 
Grade -4 00 0.0 05 16.7 
               
 
 
 The findings shows that clinical related variables of clients with diabetic foot ulcer 
Type of diet majority of the study subjects are following mixed type of diet in 
both groups 96.7 % (29) and carbohydrate rich diet subjects were in experimental 
group 3.3% (1) and in control group 3.3% (1). 
History of chronic illness in considering 73.3% (22) of them in experimental 
group and 83.3% (21) in control group were having history of chronic illness and 
were in no history of chronic illness in experimental group 26.7% (8) and in 
control group 16.7% (5). 
If yes, specify, nearly 46.7 % (14) in experimental and 50% (15) in control group 
subjects are suffering with hypertension, were in cardiovascular problem in 
experimental group 13.3% (4) and control group 20.0% (6), chronic kidney 
disease were in experimental group 10.0% (3) and control group 6.7% (2) and 
were subjects with neurological problems in experimental group 3.3% (1) and in 
control group 6.7% (2). 
History of medication for chronic illness subjects constituting the history of 
consuming medications for chronic illness is very less, in experimental group 73.3 
%( 22) and in control group 83.3 %( 25) and  no history of consuming diabetic 
medication for chronic illness in experimental group 26.7% (8) and in control 
group 16.7% 95). 
Duration of illness  the participants are having this illness about 1-2 years, i.e. 
43.3% (13) in experimental and 60% (18) in control group,2-5 years duration of 
illness in experimental group 36.7% (11) in control group30.0% (9),5-10 years 
duration of illness in experimental group 13.3% (10) and control group 6.7% (2) 
were in more than 10 years of having this illness in experimental group 10.0% (3) 
and control group 3.3% (1). 
Duration under diabetic medication  the study subjects were in taking diabetic 
treatment is about less than 2years, 43.3 %( 13) in experimental and 63.3 %( 19) in 
control group ,in 2-5 years 33.4%(10) experimental group and control group 
26.7% (8), in 5-10years were taking diabetic medication in experimental group 
13.3% (4) and control group 6.7%(2) and more than 10years were taking diabetic 
medication in experimental group 10.0% (3) and control 3.3% (1). 
Type of medication regarding the study subjects were in diet and medication 
6.7%(2)experimental group and control group 3.3%(1),were oral hypoglycaemic 
agent subjects  10.0% (3) in experimental group and control group 3.3% 
(1),insulin were in experimental group 63.3% (19) and control group 86.7 %( 26), 
subjects 20.0% (6) in experimental and 6.7 %( 2) in control group were using 
insulin  and oral hypoglycaemic agent as the drug of choice. 
Grade of diabetic foot ulcer majority of the subjects were in grade-1 diabetic 
foot ulcer in experimental 43.43%( 13) control group 33.3% (10), were grade-2 
diabetic foot ulcer in experimental  group 40.0% (12)control group 23.3 %( 
07),were have grade -3 diabetic foot ulcer 16.7% (5) in experimental group and 
control group 26.7% ( 08) and grade-4 diabetic foof ulcer were in experimental 
group 00% (0) and control group 16.7%(05). 
 
 
 
 
 
 
 
 
 
 Section-III: Distribution on grading level of diabetic foot ulcer in 
control and experimental group. 
Table 3: pretest and posttest grading level of diabetic foot ulcer  healing score 
(control) 
 
         Wagner Grading system 
  
  
Test Chi square test 
Pre test Post test 
F  % F  % 
G-0 Intact skin 00 0.0 03 10.0  
2=6.11 
  
p=0.19 
  
G-1 Superficial ulcer of skin 10 33.3 06 20.0 
G-2 Ulcers extend into tendon, bone or capsule 07 23.3 12 40.0 
G-3 Deep ulcer with osteomyelitis of abscess 08 26.7 05 16.7 
G-4 Gangrene of toes or forefoot 05 16.7 04 13.3 
G-5 Midfoot or hind foot gangrene 00 0.0 00 0.0 
                        Total 30 100.0 30 100.0  
 
In pretest  
Among control group, none of them were have intact, were had Superficial 
ulcer of skin (10) 33.3%, were had ulcers extend into tendon, bone to capsule 
23.3% (07),were in deep ulcer with osteomyelitis of abscess, 26.7%(08) and  were 
had Gangrene of toes or forefoot and 16.7%(05)none of them do not  having the 
mid foot or hind foot gangrene grade of diabetic foot ulcer. 
In posttest 
Among control group were had intact skin 10.0%(03), were had Superficial 
ulcer of skin 20.0%(06), were had ulcers extend into tendon, bone to capsule 
40.0%(12), were had deep ulcer with osteomyelitis of abscess 16.7% (05) and 
were had gangrene of toes or fore foot and 13.3%(04) were do not have the mid 
foot or hind foot gangrene of diabetic foot ulcer. Statistically there is no significant 
difference; it was confirmed using chi square test. 
 
Table 4: Pretest and posttest Grading level of diabetic foot ulcer healing score 
(experiment) 
             Wagner Grading System 
 
 
 
Test
Chi square 
test 
Pre-test Post-test 
F % F % 
G-0 Intact skin 00 0.0 07 23.3  2=8.75 
p=0.05* 
  
G-1 Superficial ulcer of skin 13 43.3 12 40.0 
G-2 Ulcers extend into tendon, bone or capsule 12 40.0 09 30.0 
G-3 Deep ulcer with osteomyelitis or  abscess 05 16.7 02 6.7 
G-4 Gangrene of toes or forefoot 00 0.0 00 0.0 
G-5 Midfoot or hindfoot gangrene 00 0.0 00 0.0 
                          Total 30 100.0 30 100.0  
 
 
In pretest  
Among Experimental group, none of them were have intact, were have 
Superficial ulcer of skin (13) 43.3%, were had Ulcers extend into tendon, bone to 
capsule 40.0%(12), were in deep ulcer with osteomyelitis of abscess, 16.7%(05) 
and were none of them do not have Gangrene of toes or forefoot and the mid foot 
or hind foot gangrene grade of diabetic foot ulcer. 
In posttest 
Among Experimental group were have intact skin 23.3%(07), were had 
Superficial ulcer of skin 40.0%(12), were had ulcers extend into tendon, bone to 
capsule 30.0%(09), were had deep ulcer with osteomyelitis of abscess 6.7% (02) 
and were none of them do not have gangrene of toes or fore foot and mid foot or 
hind foot gangrene of diabetic foot ulcer in the grading level of healing score. 
Statistically there is significant difference. 
 2=8.75 p=0.05* it was confirmed using chi square test.
Section-IV: Distribution on effectiveness of Yellow Myrobalan 
(Kadukkai) powder dressing on diabetic foot ulcer. 
Table4.5: Effectiveness of Yellow Myrobalan (Kadukkai) powder dressing on 
diabetic foot ulcer. 
Diabetic foot 
ulcer 
 Maximum 
score 
Mean 
dressing 
score 
Mean Difference 
in dressing  score  
with 95% 
Confidence 
interval 
Percentage  of   
dressing score 
with 95% 
Confidence 
interval 
Experiment Pretest 5 4.02 1.27(0.97-1.56) 25.4 % 
(19.4%-31.2%) 
Posttest 5 1.37 
Control Pretest 5 4.13 0.40(-0.01-0.69) 8.0% 
(-0.2% 13.8%) Posttest 5 3.43 
        
         Above table shows the effectiveness of Yellow Myrobalan (Kadukkai) 
powder dressing on diabetic foot ulcer. 
  Experiment clients are reduced 25.4% of dressing score after yellow 
Myrobalan powder dressing on Diabetic Foot Ulcer among clients .In Control 
clients, they are reduced 8.0% of score after having routine treatment. This shows 
the effectiveness of Yellow Myrobalan (Kadukkai) powder dressing. 
Differences between pretest and posttest score was analyzed using percentage with 
95% CI (Confidence Interval) and mean difference with 95% CI (Confidence 
Interval).   
 
 
 
 
 
 
Section-V: Distribution on comparison of wound healing process in clients with 
diabetic foot ulcer between experimental and control group. 
Table 4.6: Comparison of experiment and control group level of diabetic foot 
ulcer (pretest) 
    Wagner Grading system 
  
  
Group Chi square test 
Experiment Control 
F  % F  % 
G-0 Intact skin 0 0.0 00 0.0 2=7.40 
      p=0.06 
 
G-1 Superficial ulcer of skin 13 43.3 10 33.3 
G-2 Ulcers extend into tendon, bone or capsule 12 40.0 07 23.3 
G-3 Deep ulcer with osteomyelitis of abscess 05 16.7 08 26.7 
G-4 Gangrene of toes or forefoot 00 0.0 05 16.7 
G-3 Midfoot or hind foot gangrene 00 0.0 00 0.0 
                    Total 30 100.0 30 100.0  
 6LJQLILFDQWDW3 +LJKO\VLJQLILFDQWDW3 *** Very high 
VLJQLILFDQWDW3 
         The above table shows the comparison of pre test level of diabetic foot ulcers 
among in experimental and control group. There is no statistical significance 
found. 
Table 4.7: Comparison of experiment and control group level of diabetic foot 
ulcer (posttest.) 
        Wagner Grading system 
  
  
  
Group Chi square test 
Experiment Control 
F  % F  % 
G-0 Intact skin 07 23.3 03 10.0  
2=9.37 
p=0.05* 
  
G-1 Superficial ulcer of skin 12 40.0 06 20.0 
G-2 Ulcers extend into tendon,bone or capsule 09 30.0 12 40.0 
G-3 Deep ulcer with osteomyelitis of abscess 02 6.7 05 16.7 
G-4 Gangrene of toes or forefoot 00 0.0 04 13.3 
G-5 Mid foot or hind foot gangrene 00 0.0 00 0.0 
                             Total 30 100.0 30 100.0  
 6LJQLILFDQWDW3 +LJKO\VLJQLILFDQWDW3  *** Very high significant 
DW3 
     The above table shows the comparison of post test level of diabetic foot ulcer 
level among experimental and control group. There is a statistical significant. 
2=9.37 p=0.05*, It was confirmed using chi square test. 
 Table 4.8: Comparison of Experiment and Control group healing score in 
clients with diabetic foot ulcer. 
  
No. of  
clients 
Group 
Mean  
Difference
Student  
Independent 
t-test
Experiment Control 
Mean SD
Mea
n SD
Pre-test  
 
30 
 
3.23 0.73 3.30 0.84 0.07 
2=0.32 
p=0.74 
  
 
 
 
Post-test 
 
 
30 
 
1.97 1.03 2.90 1.12 0.93 
2=3.34 
p=0.001*** 
  
       
  
             The above table shows the comparison of healing score between 
experimental and control group. There is significant mean difference among pre 
and post test scores in experimental group. The mean difference is 0.93, 2=3.34 
p=0.001*, this results shows statistically significant. 
 
 
Table 4.9: Comparison of pretest and posttest dressing score 
Diabetic foot 
ulcer 
  
 
No. of  
clients 
Group 
Mean  
Difference 
Student  
paired t-test 
Pre-test Post-test 
Mean SD Mean SD 
 
 
 
Experiment 
 
 
    
    30 
3.23 0.73 1.97 1.03 1.26 
2=8.83 
p=0.001*** 
  
 
 
 
Control 
 
 
    30 
 3.30 0.84 2.90 1.12 0.40 
2=1.87 p=0.06 
  
 
 
6LJQLILFDQWDW3 
+LJKO\VLJQLILFDQWDW3 
9HU\KLJKVLJQLILFDQWDW3 
Above table shows the comparison of mean wound dressing score of 
experimental and control group. 
Experiment group 
In Mean pretest, clients were have 3.23 dressing score and in posttest, they 
were have 1.97 score. Difference is 1.26 score. The difference between pretest and 
posttest score is large and it is statistically significant. Differences between pretest 
and posttest score was analyzed using Student paired-test.  
Control group 
In Mean pretest clients were have 3.30 dressing score and in posttest, they 
were have 2.90 score. Difference is 0.40score.The difference between pretest and 
posttest score is small and it is not statistically significant. Differences between 
pretest and posttest score was analyzed using Student paired t-test. 
 
Section-VII: Distribution on association between wound healing process and 
Yellow Myrobalan(Kadukkai) powder dressing with selected demographic 
variables and clinical related variables among experimental group.  
Table 4.10: Association between level of Yellow Myrobalan (Kadukkai) 
powder dressing score and demographical variables (Experimental Group) 
s.no 
DEMOGRAPHIC VARIABLES 
Level of Dressing score 
Total 
Chi square 
test 
Below 
DYHUDJH 
Above 
average(>1.27)% 
1. Age 
  
  
  
40 -49 years 2 22.2 7 77.8 9 
2=7.55 
p=0.05* 
  
50 -59 years 6 46.1 7 53.9 13 
60 -69 years 5 83.3 1 16.7 6 
\HDUV 2 100.0 0  0.0  2 
2. Gender 
  
Male 12 54.5 10 45.5 22  2=0.68     
p=0.40,  Female 3 37.5 5 62.5 8 
3. Marital 
Status 
   
  
Married 11 55.0 9 45.0 20 
2=3.34 
p=0.34,  
Unmarried     2 100.0 2 
Divorced/Separated     1 100.0 1 
Widower/Widow 4 57.1 3 42.9 7 
4. Religion 
  
  
Hindu 12 52.2 11 47.8 23 2=1.37 
p=0.50 
  
Christian 1 25.0 3 75.0 4 
Muslim 2 66.7 1 33.3 3 
5. Type of 
Family 
  
  
Nuclear Family 5 41.7 7 58.3 12 2=3.33 
p=0.17 
  
Joint Family 10 62.5 6 37.5 16 
Broken Family     2 100.0 2 
6. Education 
Status 
  
  
  
Illiterate 6 75.0 2 25.0 8 
2=8.53 
p=0.03* 
 
Elementary 9 50.0 9 50.0 18 
Higher Secondary 0  0.0  2 100.0 2 
Graduate and above 0  0.0  2 100.0 2 
7. Occupation 
  
  
 
House Wife 2 100.0 0  0.0  2 
2=6.14 
p=0.18,  
Government 1 25.0 3 75.0 4 
Private 5 35.7 9 64.3 14 
Pensioner 4 80.0 1 20.0 5 
Unemployed 3 60.0 2 40.0 5 
8. Income 
  
  
  
< Rs.3000 3 60.0 2 40.0 5 
2=1.81 
p=0.61 
  
Rs.3001-5000 2 28.6 5 71.4 7 
Rs.5001-8000 7 58.3 5 41.7 12 
> Rs.8001 3 50.0 3 50.0 6 
9. Area of 
Residence 
  
Rural 6 54.5 5 45.5 11 2=0.14 
p=0.70,  Urban 9 47.4 10 52.6 19 
10. Dietary 
Pattern 
Vegetarian 6 66.7 3 33.3 9 2=0.41 
p=0.81 
  
Non-Vegetarian 2 33.3 4 66.7 6 
Mixed Diet 7 46.7 8 53.3 15 
 
 Above table shows the association between level of reduction of Yellow 
Myrobalan (Kadukkai)powder dressing on Diabetic Foot Ulcer and demographic 
variables among clients in the experimental group .Elder and more educated are 
reduced more score than others. Statistical significance was calculated using chi 
square test. 
Significant variables 
Age distribution, the study participants in experimental group 22.2% (2) below 
average and above average 77.8%(7)were belongs to the age group 40-49 years 
and below average 46.1%(6) and above average 53.9%(07) age group between 50-
59 years in experimental group, below average 83.3%(05) and above average 
16.7% (1) age group 60-69years in experimental group  and were in 7o and above 
70years in experimental group below average 100.0%(2) and above average 0.0%  
P=0.05* significant variable 
Educational status, majority of them were educated up to illiterate level in 
experimental group below average 75.0%(06) and above average 25.0%(2), 
elementary subject were in below average 50%(09) and above average 50% (09) 
in experimental group and higher secondary subjects were in below average 
0.0%(0) and above average 100%(2) and graduate and above subjects were below 
average 0.0% (0) and above average 100.0% (2) in experimental group.                       
P=0.03* Significant variable. 
            There was significant association between these demographic variables 
among clients with diabetic foot ulcer in the experimental group. 
 
 
 
 
 
 
 
 
 
Table 4.11: Association between level of Yellow Myrobalan(Kadukkai) 
powder dressing score and demographical variables (Control Group) 
s.no  Level of Dressing score Total Chi square test 
Demographic variables %HORZDYHUDJH Above 
average(>0.40) 
  F       % F       % 
1. Age 
  
  
  
40 -49 years 6 40.0 9 60.0 15 2=3.30 
p=0.35 
  50 -59 years 5 62.5 3 37.5 8
60 -69 years 2 40.0 3 60.0 5 
\HDUV 2 100.0     2 
2. Gender 
  
Male 8 50.0 8 50.0 16 2=0.00 
p=1.00 Female 7 50.0 7 50.0 14 
3. Marital Status 
  
  
Married 11 50.0 11 50.0 22 2=3.20 
p=0.36 
  Unmarried     1 100.0 1 
Divorced/Separated 2 100.0     2 
Widower/Widow 2 40.0 3 60.0 5 
4. Religion 
  
  
Hindu 11 55.0 9 45.0 20 2=4.20 
p=0.12 
 Christian 2 25.0 6 75.0 8 
Muslim 2 100.0     2 
5. Type of Family Nuclear Family 6 42.9 8 57.1 14 2=1.35 
p=0.51 Joint Family 8 53.3 7 46.7 15 
Broken Family 1 100.0     1 
6. Educational 
Status 
  
  
  
Illiterate 3 50.0 3 50.0 6 2=2.21 
p=0.53 
  Elementary 7 46.7 8 53.3 15 
Higher Secondary 3 42.9 4 57.1 7 
Graduate and above 2 100.0     2 
7. Occupation 
  
  
  
  
House Wife 2 100.0     2 2=4.52 
p=0.33 
  Government 3 50.0 3 50.0 6 
Private 7 41.2 10 58.8 17 
Pensioner 3 75.0 1 25.0 4 
Unemployed     1 100.0 1 
8. Income 
  
  
  
< Rs.3000 3 60.0 2 40.0 5 2=2.22 
p=0.56 
  Rs.3000-5000 1 33.3 2 66.7 3 
Rs.5000-8000 5 38.5 8 61.5 13 
> Rs.8000 6 66.7 3 33.3 9 
9. Area of 
Residence 
  
Rural 8 66.7 4 33.3 12 2=2.23 
p=0.16 Urban 7 38.9 11 61.1 18 
10. Dietary Pattern 
  
  
Vegetarian 5 62.5 3 37.5 8 2=1.30 
p=0.52 
  Non-Vegetarian 2 66.7 1 33.3 3 
Mixed Diet 8 42.1 11 57.9 19 
Above Table shows the association between level of reduction of [Yellow 
Myrobalan(Kadukkai)] powder dressing on Diabetic Foot Ulcer and demographic 
variables among clients in the control group. None of the variables are significant. 
Statistical significance was calculated using chi square test. 
Table 4.12: Association between level of Yellow Myrobalan (Kadukkai) 
powder dressing score and clinical related variables (Experiment) 
s.n
o 
 Clinical related variables 
  
Level of Dressing score 
Total 
Chi square 
test 
Below 
DYHUDJH 
Above 
average(>1.27) 
F  % F  % 
1. Type of Diet 
  
Carbohydrate Rich 
Diet     1 100.0 1 
2=1.03 
p=0.31 
  Mixed Diet 15 51.7 14 48.3 29 
2. H/o. Chronic 
Illness 
  
Yes 14 63.6 8 36.4 22 2=6.13 
p=0.01*  No 1 12.5 7 87.5 8 
If yes, 
Specify 
  
  
  
  
Nil  1 12.5 7 87.5 8 
2=6.05 
p=0.08 
  
Hypertension 7 50.0 7 50.0 14 
Cardiovascular 
problems 4 
100.
0     4 
Chronic Kidney 
Disease 3 
100.
0     3 
Neurological 
Problems     1 100.0 1 
3. H/o. Any 
Medication 
for Chronic 
Illness 
  
Yes 12 
 
54.5 
 
10 
 
45.5 
 
22 
 2=0.68 
p=0.40 
  
No 
03 37.5 05 62.5 08 
4. Duration of 
Illness 
  
  
  
1-2 Years 4 30.7 9 69.3 13 
2=8.01 
p=0.05* 
  
2-5 Years 5 45.5 6 55.5 11 
5-10 Years 3 100.0 0 0.0 3 
>10 Years 3 100.0 0 0.0 3 
5. Duration 
Under 
Diabetic 
Medication 
 
< 2Years 6 46.2 7 53.8 13 
2=1.81 
p=0.61 
  
2 - 5 Years 6 60.0 4 40.0 10 
5 -10Years 1 25.0 3 75.0 4 
>10 Years 2 66.7 1 33.3 3 
6. Type of 
Medication 
  
  
  
Diet and Medication 1 50.0 1 50.0 2 
2=1.05 
 p=0.78 
 
  
OHA-Oral 
Hypoglycaemic 
Agent 
1 33.3 2 66.7 3 
Insulin 9 47.4 10 52.6 19 
Insulin and Oral 
Hypoglycaemic 
Agent 
4 66.7 2 33.3 6 
7. Grade of 
D/F/U 
  
  
  
Grade -1 3 23.1 10 76.9 13 
2=6.90 
p=0.03* 
  
Grade -2 8 66.7 4 33.3 12 
Grade -3 4 80.0 1 20.0 05 
Grade -4 0 0.0 0  0.0  00 
 
 Above table shows the association between level of reduction of Yellow 
Myrobalan (Kadukkai) powder dressing on diabetic foot ulcer and treatment 
related variables among clients in the experiment group.No chronic illness and less 
duration of illness clients are benefitted more than others.  
Statistical significance was calculated using chi square test. 
Significant variables 
History of chronic illness in considering below average 63.3% (14) above 
average were 36.4%(8)  them in experimental group and subjects were no history 
of chronic illness in experimental group below average 12.5% (1) and above 
average 87.5%% (07). 
 P=0.01** highly significant. 
Duration of illness  the participants were have this illness about 1-2 years in 
below average 30.7%(4) and above average were 69.3% (09) in experimental 
group and were have 2-5 years duration of illness in experimental group below 
average were 45.5% (05) and above average were 55.5% (06) and subjects were 
have 5-10 years duration of illness in experimental group below average were 
have 100.0% (3) and above average 0.0% (0)and subjects were more than 10 years 
of having this duration of illness in experimental group below average were have 
100%(03) and above average were 0.0%(0). 
   P=0.05*significant  
Grade of diabetic foot ulcer majority of the subjects were in grade-1 diabetic 
foot ulcer in experimental  group below average 23.1% (03)and above average 
were have 76.9% (13), were  have grade-2 diabetic foot ulcer in experimental  
group below average 66.7% (08) and above average were 33.3% (12),were have 
grade -3 diabetic foot ulcer in experimental group below average were 80.0%(04) 
and above average 20.0%(05) and grade-4 diabetic foot ulcer subjects were in 
experimental group below average and above average have 00% (0). 
P=0.03*significant. 
Table 4.13: Association between levels of Yellow Myrobalan (Kadukkai) 
powder dressing Score and clinical related variables (control) 
s.no 
 Clinical related variables 
  
Level of Dressing score 
Total 
Chi 
square test 
Below 
DYHUDJH 
Above 
average(>0.40) 
F  % F  % 
1. Type of Diet 
  
Carbohydrate Rich 
Diet 1 100.0 0  0.0  1 
2=1.03 
p=0.31 
  Mixed Diet 14 48.3 15 51.7 29 
2. History of Chronic 
Illness 
  
Yes 13 52.0 12 48.0 25 2=0.24 
p=0.62 
  
No 2 40.0 3 60.0 5 
3. If yes, Specify 
  
  
  
  
0 2 40.0 3 60.0 5 
2=0.93 
p=0.92 
  
Hypertension 7 46.7 8 53.3 15 
Cardiovascular 
problems 4 66.7 2 33.3 6 
Chronic Kidney 
Disease 1 50.0 1 50.0 2 
Neurological 
Problems 1 50.0 1 50.0 2 
4. History of Any 
Medication for 
Chronic illness 
  
Yes 13 52.0 12 48.0 25 2=0.24 
p=0.62 
  
No 
2 40.0 3 60.0 5 
5. Duration of illness 
  
  
  
1-2 Years 9 50.0 9 50.0 18 
2=3.11 
p=0.37 
  
2-5 Years 4 44.4 5 55.6 9 
5-10 Years 2 100.0     2 
>10 Years     1 100.0 1 
6. Duration Under 
Diabetic Medication 
  
  
  
< 2Years 9 47.4 10 52.6 19 
2=1.55 
p=0.67 
  
2 - 5 Years 5 62.5 3 37.5 8 
5 -10Years 1 50.0 1 50.0 2 
>10 Years  0  00 1 100.0 1 
7. Type of Medication 
  
  
  
Diet and Medication  0  00 1 100.0 1 
2=4.15 
p=0.24 
  
OHA-Oral 
Hypoglycaemic Agent 1 100.0 0  0.0  1 
Insulin 12 46.2 14 53.8 26 
Insulin and Oral 
Hypoglycaemic Agent 2 100.0  0  00 2 
8. Grade of D/F/U 
  
  
  
Grade -1 4 40.0 6 60.0 10 
2=1.47 
p=0.69 
  
Grade -2 3 42.8 4 57.2 07 
Grade -3 5 62.5 3 37.5 08 
Grade -4 3 60.0 2  40.0  05 
 Above table shows the association between level of reduction of Yellow 
Myrobalan (Kadukkai) powder dressing on diabetic foot ulcer and treatment related 
variables among clients in the control group .None of the variables are statistically 
significant.                                          
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CHAPTER V 
SUMMARY OF THE RESULTS 
This chapter deals with the detailed summary of the results findings of the 
study obtained from the statistical analysis. The purpose of the study was to assess 
the effectiveness of Yellow Myrobalan (Kadukkai) powder dressing on wound 
healing process among diabetic foot ulcer clients admitted in selected ward, at 
Rajiv Gandhi Government General Hospital, Chennai.  
 Extensive literature review and studies related to supervised procedure of 
Yellow Myrobalan (Kadukkai) powder dressing to improve the wound healing 
activity among diabetic foot ulcer clients to provided evidenced based nursing care 
and guidance for the study. This has helped to design the research study 
methodology, and to develop the tool for data collection and the protocol for the 
intervention of Yellow Myrobalan (Kadukkai) powder dressing. The conceptual 
IUDPHZRUNGHYHORSHGIRUWKHVWXG\ZDVEDVHGRQWKH0RGLILHG2UHP¶V WKHRU\RI
self ±care deficit. 
 The tool used for data collection was validated by the experts from the area 
of medical, nursing and statistician. Reliability of the tool was assessed by using 
inter rater reliability correlation coefficient. The instrument was found to be 
reliable. Pilot study was conducted on 10 samples to find out the appropriateness 
and feasibility of conducting the study and it was found feasible. 
             Formal written permission was obtained from the Director and professor, 
Institute of diabetology and Institute of General Surgery. The data collection 
period was four weeks from 15.07.2015 to 14.082015, done in selected ward at 
Rajiv Gandhi Government General Hospital, Chennai. 
             Study samples were collected by method of simple random sampling 
technique, selected samples were divided as two groups by selecting odd numbers 
and even numbers, odd numbers were allotted for experimental group and even 
numbers were allotted as control group and who fulfilled the inclusion criteria, 
were included in the study.  
            Pre-assessment of the wound was done by using Wagner Wound 
Assessment Scale and the characteristics of the foot ulcer was pre-assessed with 
help of Wound  Assessment  Scale in both Experimental and Control on the first 
day of the study. The intervention of Yellow Myrobalan (Kadukkai) powder 
dressing procedure was performed to Experimental group daily for 21 consecutive 
days. Control group received their routine care. The wound assessment was done 
on daily during the intervention period. 
            Post-assessment of the foot ulcer was done with the help of same Wound 
Assessment Scale on the end of the 21st day. The evidence of intervention and 
wound healing were marked. Intervention was done at the bedside. 
Descriptive statistics (percentage, frequency distribution, mean and 
standard deviation) and inferential statistics (t-test, chi-square test) were used to 
analyze the data and to assess the hypothesis. The data were then interpreted and 
discussed based on the objectives of the study, hypotheses and relevant studies 
from literature reviewed. 
The summary of the results findings of the study will be discussed based on 
the objectives.  
Findings of the study results of the demographic variables were described in 
the forms of frequency and percentage distribution. 
 Majority of the study participants in experimental group 43.3% were 
belongs to the age group 50-59 years. Were as in control group majority 
(50%) of them were in the age group between 40-49 years. 
 Regarding the gender distribution majority of them were males 73.3% 
(Experimental), 53.3% (Control). 
 Higher numbers of married subjects participated in this study 66.6% 
(Experimental), 73.3% (Control). 
 Most of them were Hindus 76.7 % (Experimental), 66.6% (Control). 
 Nearly 53.3% in experimental and 50% in control group members living in 
joint family 
 Majority of them were educated up to primary level in this study 60%in 
experimental and 50% in control. 
 Experimental group 46.7% in and 56.7% in control group members were 
working in private concerns. 
  Almost all the study participants were belongs to low socio economic 
status among that around 40% in experimental and 43.3% in control group 
was having monthly income about Rs 5001-8000. 
 Majority of the clients were from urban community 63.3% in experimental 
and 60% in control group. 
 50%in experimental and 63.3% in control group members were following 
mixed group dietary pattern. 
Findings of the study results the clinical related variables were described in 
the forms of frequency and percentage distribution. 
 Majority of the study subjects were following mixed type of diet in both 
groups (96.7%) 
 73.3% of them in experimental group and 83.3% in control group were 
having history of chronic illness. 
 Nearly 46.7% in experimental and 50% in control group subjects were 
having Hypertension. 
 73.3% in experimental and 83.3% in control group members were taking 
medications for chronic illness. 
 Majority of the participants were had this illness about less than 2 years, i.e. 
43.3% in experimental and 60% in control. 
 Most of the study subjects were in taking diabetic treatment was about  
< 2years, 43.3% in experimental and 63.3% in control group. 
  Experimental group 63.3% and 86.7% in control group were using insulin 
as the drug of choice. 
 Majority of the subjects were have grade 1 diabetic foot ulcers in pretest of 
experimental group 43.3 % (13) and  post test 40.0%(12). 
 In pretest majority of study subjects among control group were have 
superficial ulcer of skin 33.3 % (10). 
 Inpost test majority of study subjects among were haveulcers extend into 
tendon, bone or capsule 40.0% (12) belongs to control group. Statistically 
there was no significant difference. It was confirmed by using chi square 
test 
 Regarding the majority of study subjects in pretest of experimental group 
clients were having3.23 dressing score and in posttest, theywere having 
1.97 score difference was 1.26 score.  The difference between pretest and 
posttest   score was large and it was statistically significant. Differences 
between pretest and posttest score was analyzed using Student pairedt-test.  
 Considering control group in pretest clients were have 3.30 dressing score 
and in posttest, they were having 2.90 score. Difference was 0.40 score. 
The difference between pretest and posttest score was small and it was not 
statistically significant. Differences between pretest and posttest score was 
analyzed using Student paired t-test. 
 On an average, experiment clients were reduced 25.4% of dressing    score 
after yellow Myrobalan (Kadukkai) powder dressing on diabetic foot ulcer 
among clients .In Control clients, they were reduced 8.0% of score after 
having routine treatment. This shows the effectiveness of Yellow 
Myrobalan (Kadukkai) powder dressing. Differences between pretest 
and posttest score was analyzed using percentage with 95% CI and mean 
difference with 95% CI.   
 
 
CHAPTER-VI 
DISCUSSION 
This chapter deals with the detailed discussion of the study obtained from 
the statistical analysis. The purpose of the study were to assess the effectiveness of 
Yellow Myrobalan (Kadukkai) powder dressing on to improving and promoting 
the wound healing process in clients with diabetic foot ulcer who were admitted in 
selected wards, at Rajiv Gandhi Government General Hospital, Chennai. 
Diabetes is a disease which needs lifelong treatment. If untreated or 
improperly treated diabetes can leads to so many ill effects; it shortens life 
considerably or debases its quality substantially. Research has shown that 
improved wound healing process in the diabetic patient with foot ulcer in the 
Experimental group had improved the wound healing activity and thereby faster 
wound healing of the foot ulcer. So in addition to the pharmacological treatment. 
 Yellow Myrobalan (Kadukkai) powder dressing can be used as an effective 
complimentary treatment modality for managing diabetic foot ulcer. On an 
average, experiment clients were reduced 25.4% of dressing    score after yellow 
Myrobalan powder dressing on Diabetic Foot Ulcer among clients .In Control 
clients, they were reduced 8.0% of score after having routine treatment. This 
shows the effectiveness of Yellow Myrobalan (Kadukkai) powder dressing. 
Differences between pretest and posttest score was analyzed using percentage with 
95% CI and mean difference with 95% CI (confidence interval).The future of this 
field of nursing science promised to be one of the rapid significant growths, the 
results of which will directly influence patient care in the aspect of promoting 
ZRXQGKHDOLQJDVWKDWRI³HYLGHQFHGEDVHGQXUVLQJFDUH´ 
 
 
 
 
Objective I: The first objective of the study is to assess the grading level of 
diabetic foot ulcer among clients. 
In pretest among control group, none of them were have intact, were 
hadSuperficial ulcer of skin (10) 33.3%, were had Ulcers extend into tendon, bone 
or capsule 23.3% (07), were in deep ulcer with osteomyelitis of abscess, 
26.7%(08) and were had Gangrene of toes or forefoot and 16.7%(05) none of them 
not having the midfoot or hind foot gangrene grade of diabetic foot ulcer. 
In pretest among experimental group, none of them were have intact, were 
had Superficial ulcer of skin (13) 43.3%, were had Ulcers extend into tendon,bone 
to capsule 40.0%(12), werein deep ulcer with osteomyelitis of abscess, 16.7%(05) 
and were none of them nothave Gangrene of toes or forefoot and the midfoot or 
hind foot gangrene grade of diabetic foot ulcer. 
                        This study is supported by NaliniSingh, David G.Armstrong, 
Benjamin A. Lipsky; et.al (2005) conducted a study on Prevention of diabetic 
foot ulcers. Which was best accomplished in the primary care setting with a brief 
history and the Semmes-Weinstein monofilament. Educating clients about proper 
foot care and periodic foot examinations were effective interventions to prevent 
ulceration. Other possibly effective clinical interventions include optimizing 
glycemic control, smoking cessation, intensive podiatric care, debridement of 
calluses, and certain types of prophylactic foot surgery. The value of various types 
of prescription footwear for ulcer prevention was not clear. 
Objective II: To evaluate the effectiveness of Yellow Myrobalan (Kadukkai) 
powder dressing on wound healing among experimental group as post-test. 
In the effectiveness among  experiment group were reduced 25.4% of 
wound dressing score after yellow Myrobalan powder dressing on Diabetic Foot 
Ulcer among clients .In Control clients, they were reduced 8.0% of score after 
having routine treatment. This shows the effectiveness of yellow Myrobalan 
 
 
powder dressing. Differences between pretest and posttest score was analyzed 
using percentage with 95% CI and mean difference with 95% CI.   
 R Rathinamoorthy et al., (2012) Reported as the study was focused 
on treatment of water and methanol extracts of Terminalia chebula fruits act as a 
cross linking agent on cotton plain-woven fabric. The fabric samples were tested 
for antibacterial activity against bacterial Staphylococcus aureus, Escherichia coli, 
Klebsiella pneumoniae, Proteus vulgaris, and Salmonella typhi under agar 
diffusion strains like test and quantitative analysis. The results indicated that the 
treated cotton fabric shows a clear microbial resistance with 27-38mm zone of 
inhibition in the agar diffusion test against all the above mentioned strains. The 
treated samples showed 99% of reduction against Staphylococcus aureus and 
86.25% reduction against Escherichia coli as per quantitative analysis. Box 
Behnken design and the correlation coefficient was found to be 0.932 in the case 
of Staphylococcus aureus and 0.66 in the case of Escherichia coli. 
 
Objective III: To compare the wound healing process between 
Experimental and control group. 
Among control group were had intact skin 10.0%(03), were had Superficial 
ulcer of skin 20.0%(06), were had ulcers extend into tendon, bone to capsule 
40.0%(12), werehad deep ulcer with osteomyelitis of abscess 16.7% (05) and were 
had gangrene of toes or forefoot and 13.3%(04) were not have the midfoot or hind 
foot gangrene of diabetic foot ulcer. Statistically there is no significant difference; 
it was confirmed using chi square test. 
           Among Experimental group were had intact skin 23.3%(07), were 
had Superficial ulcer of skin 40.0%(12), were had ulcers extend into tendon, bone 
to capsule 30.0%(09), werehad deep ulcer with osteomyelitis of abscess 6.7% (02) 
and were none of them not have gangrene of toes or fore foot and midfoot or hind 
foot gangrene of diabetic foot ulcer in the grading level of healing score. 
Statistically there is significant difference. 
 
 
2=8.75 p=0.05*it was confirmed using chi square test. 
 
               In mean pretest, clients were have 3.23 dressing score and in posttest, 
they were have 1.97 score. Difference is 1.26 score. The difference between 
pretest and posttest score is large and it is statistically significant. Differences 
between pretest and posttest score was analyzed using Student paired-test. 
This Study was Supported by Vimala G et al., (2010) conducted a study on 
promoting wound healing activity, in ayurvedic study Terminaliachebula 
(combretaceae) was FRPPRQO\ NQRZQ DV¶¶P\UREDODQ LW was locally called 
µ¶NDGXN-NDL¶This drug available in powder form also make an excellent paste as 
an application for chronic ulcerations and ulcerated wounds and it also called as 
µNLQJ RI PHGLFLQH¶ because of its, extraordinary power of wound healing. This 
medicine has been demonstrated to possess multiple pharmacological and 
medicinal activities such as anti diabetic; anti-inflammatory and wound healing 
activity and also Antibacterial activity of Terminalia chebula extracts against 
several bacterial strains have been reported. Extracts from different parts of 
diverse species of plants like root, flower, leaves, seeds, etc. exhibit antibacterial 
properties were applied on cotton material for wound, following in our traditional 
practice. 
Objective IV: To find the association between wound healing process and 
Yellow Myrobalan (Kadukkai) powder dressing with selected demographic 
variables and clinical related variables among experimental group. 
In the association between levels of wound healing gain score and their 
demographic variables in experimental group in Yellow Myrobalan (Kadukkai) 
powder dressing on Diabetic Foot Ulcer and demographic variables among clients 
in the experimental group .Elder and more educated were reduced more score than 
others. Statistical significance was calculated using chi square test. 
In the association between levels of wound healing gain score with Yellow 
Myrobalan (Kadukkai) powders dressing on Diabetic Foot Ulcer and treatment 
 
 
related variables among clients in the experiment group .no chronic illness and 
less duration of illness clients were benefitted more than others. Statistical 
significance was calculated using chi square test. 
Hypothesis 
           H1:  There was a statistically significant difference between pretest and 
posttest level of grading of wound healing among clients with diabetic foot ulcer 
by doing the procedure of Yellow Myrobalan (Kadukkai) powder dressing among 
clients. (Objective III). 
           H2: There was a statistically significant association between the post test by 
level of grading of wound healing after the dressing procedure among diabetic foot 
ulcer clients with selected variables. (Objective IV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER VII 
CONCLUSION AND RECOMMENDATIONS 
Diabetic foot ulcer is the most serious and costly complications and 
important cause of morbidity in diabetic people over the years. Diabeticfoot ulcers 
are the sores that occur on the feet of the people with Type 1 and Type 2 diabetes 
mellitus. Diabetic foot ulcer is defined as major erosions of the epithelium that 
extends into the dermis and deeper tissues and is associated with reduced healing 
capacity (kinmond-2003).The main risk factors that causes diabetic foot ulcer are 
peripheral neuropathy and micro as well as macro vascular ischemia. Peripheral 
neuropathy causes loss of pain or feeling into the toes, legs, and arms due to the 
distal nerve damage and low blood flow supply (atherosclerosis), very less oxygen 
supply, and eventually death of tissue in feet occurs. 
                       This chapter explains about limitations of the study, implications 
and recommendations were given for different areas of nursing such as practice, 
administration, education,and research in the Health care delivery system.               
7.1. Nursing Implication 
The finding of the study have the following implications in different branch 
of nursing that is, nursing practice, nursing education, nursing administration and 
nursing research results.By evaluating the effectiveness Kadukkai powder dressing 
among the patients with diabetic foot ulcer the investigator received a clear picture 
regarding the different steps to be taken in different fields to improve the same. 
 
Implications for Nursing Practice  
¾  Yellow Myrobalan (Kadukkai) powder dressing was  an effective measure 
to promote wound healing activity nurse should effectively use this 
measure to promote wound healing capacity. 
 
 
¾ Kadukkai powder dressing helps in reducing the need and frequency of 
administration of antibiotics. 
¾ Kadukkai powder dressing promotes purifying,hastening and cleansing 
capacity of the wound. 
¾ Nurses can plan the goal of nursing management and enhance the nurse 
patient relationship and sense of well being o the patient through the 
development of mutually agreeable goals. 
¾ It was  an effective means of communication which provides physical 
contact in a very acceptable way within the Indian culture. 
¾ Kadukkai powder dressing can be taught to the loved ones who were caring 
for diabetic patients with foot ulcer. 
Implications for Nursing Administration 
¾ Nursing administrator should conduct in-service education program for 
staff nurses about caring patients with Diabetic foot ulcer. 
¾ Nursing administrator should supervise anG JXLGH QXUVH¶V DSSOLFDWLRQ RI
dressing and care of foot ulcer.  
¾ Nursing administrator should monitor the standard of practice to promote 
excellence of caring patients with diabetic foot ulcer. 
Implications for Nursing Education 
¾ Kadukkai powder dressing need to be included in the curriculum and 
practiced. 
¾ In service education programme should be conducted for nursing personnel 
and help nurse to gain knowledge upon which further researches can be 
conducted. 
Implications for Nursing Research 
¾ Nursing researcher should encourage the clinical nurse to apply the 
research findings in this daily nursing care activity. 
 
 
¾ Nursing researcher should motivate the clinical nurse to do further research 
studies on the effect of Kadukkai powder dressing on promoting wound 
healing process. 
¾ Nursing researcher should conduct periodic review of research findings and 
disseminate findings through conference, national and international 
journals. 
7.2 Limitations of the study 
 The study was limited a period of four weeks. 
 The study was limited to only 40 and above old subjects. 
 Only 60 subjects were taken for this study. 
 The study was limited to only one hospital. 
 The time period under taken for the study was not sufficient to monitor 
the progress of the wound status. 
7.3 Recommendations for further study 
 Randomized controlled trial can be done. 
 Similar study can be conducted for a larger group. 
 Effect of Kadukkai powder dressing for a prolonged period can be 
studied. 
 A comparative study can be conducted to assess the effectiveness of 
Kadukkai powder dressing and combination with other products used for  
routine dressing care. 
 The staff nurses can implement this mode of dressing for diabetic foot 
ulcer after proper education on application of Kadukkai powder for 
wound healing. 
 The staff nurses can be trained to assess the wound characteristics to 
monitor for wound healing. 
 Further research can be conducted with the help of other wound 
assessment scale. 
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^d/KE͚͛DEMOGRAPHIC PROFILE 
1. Age of the person 
    (A) 40-49 Years 
    (B) 50-59 Years 
    (C)  60-69 Years 
    (d) 70 and above 
2. Gender 
    (A) Male 
    (b) Female 
3. Marital Status 
    (a) Married 
    (b) Unmarried 
    (c) Divorced/Separated 
    (d) Widower/Widow 
4. Religion 
    (a) Hindu                                                                                                    
    (b) Christian 
    (c) Muslim  
    (d) Others 
5. Type of Family 
    (a) Nuclear Family 
    (b) Joint Family 
    (c) Broken Family 
    (d) Paying Guest 
 6. Educational Status 
    (a) No formal education 
    (b) Elementary 
    (c) Higher Secondary 
    (d) Graduate and above 
7. Occupation 
    (a) House Wife 
    (b) Government 
    (C) Private 
    (d) Pensioner 
    (e) Unemployed 
8. Family Monthly Income(Rupees) 
    (a) 3000 
    (b) 3001-5000 
    (c) 5001-8000 
    (d) 8001 
9. Area of Resistance 
     (a) Rural 
     (b) Urban 
10. Dietary Pattern 
     (A) Vegetarian 
     (b) Non-Vegetarian 
     (c)  Mixed Diet 
 
(SECTION-B)     CLINICAL RELATED INFORMATION 
1. Type of Diet 
     (a) Carbohydrate Rich Diet Ƒ  
     (b) Cholesterol Rich Diet Ƒ 
     (c) Protein Rich Diet Ƒ 
     (d) Mixed Diet Ƒ 
2. History of Chronic Illness 
     (A) Yes                Ƒ                         (B) No Ƒ 
2. (A) If yes, Specify 
     (a) Hypertension  Ƒ 
     (b) Cardiovascular problems  Ƒ 
     (c) Chronic Kidney Disease  Ƒ 
     (d) Neurological Problems  Ƒ 
3. History of Consuming Any Medication for the chronic illness, 
      (a) Yes                         Ƒ                           (b) No  Ƒ 
3. (A) If Yes, Specify 
4. Duration of Illness (Type 1/Type 2 DM).  
     (A) 1-2 Years  Ƒ 
     (B) 2-5 Years  Ƒ 
     (C) 5-10 Years  Ƒ 
     (d) >10 Years  Ƒ 
5. The Duration of which she (or) he under Diabetic Medication. 
     (a) <  Ƒ 
     (B) 2-5 Years Ƒ 
     (c) 5-10Years Ƒ 
     (d)>10Years Ƒ 
6. Type of Diabetic Medication. 
      (a) Life-style modification (Diet and Medication) Ƒ 
      (b) OHA-Oral Hypoglycemic Agent Ƒ 
      (c) Insulin Ƒ 
      (d) Insulin and Oral Hypoglycemic Agent  Ƒ 
7. Grade of Diabetic Foot Ulcer 
       (a) Grade -0 Ƒ 
       (b) Grade -1 Ƒ 
       (c) Grade -2 Ƒ 
       (d) Grade -3 Ƒ 
       (e) Grade -4 Ƒ 
       (f)  Grade -5 Ƒ 
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                                       SECTION III 
 
                 WAGNER WOUND ASSESSMENT SCALE 
 
S.NO                  CHARECTERISTICS              
SCORE         
    1. Intact Skin         0 
    2. Superficial ulcer of skin or subcutaneous tissue         1 
    3. Ulcers extend into tendon, bone, or capsule         2 
    4. Deep ulcer with osteomyelitis, or abscess         3 
    5. Gangrene of toes or forefoot           4 
    6. Midfoot or hind foot gangrene         5 
 
 
 
 
                               GRADE-0 DIABETIC FOOT ULCER 
 
 
                          GRADE-1 DIABETIC FOOT ULCER 
 
 
                           GRADE-2 DIABETIC FOOT ULCER 
  
 
                        GRADE-3 DIABETIC FOOT ULCER 
 
 
 
                              GRADE-4 DIABETIC FOOT ULCER 
 
 
                              GRADE-5 DIABETIC FOOT ULCER 
 
 
HEALING STAGES OF DIABETIC FOOT ULCERS 
       1. More exudating, severely edematous, necrotized wound 
       2. More exudating, edematous, necrotized wound 
       3. More exudating, edematous wound 
       4. Exudating, edematous wound 
       5. Less exudating, less edematous and less epithelial zed wound 
       6. More epithelialzed wound 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 

                               PATIENT   CONSENT   FORM 
 
TITLE:  A Study to assess the effectiveness of Yellow Myrobalan (Kadukkai) 
powder dressing on wound healing in clients with diabetic foot ulcer in selected 
wards, at Rajiv Gandhi Government General hospital, Chennai. 
 
Name of the Participants         : 
Date           : 
Age/Sex                    : 
Name Of The Investigator      :  Mrs.J.Jayanthi 
Name Of The Institution         : Rajiv Gandhi Government General Hospital,  
              Chennai. 
Enrollment no                   : 
 
Documentation of the informed consent: 
 I have read/it has been Read for me, the information in this form. I was free 
to ask any questions and they have been answered am over 18 years of age 
and exercising my free power of choice, hereby give my consent to be 
included as a participant in the study. 
 I have read and understood the consent form and the information provided 
to me. 
 I  had the consent document explained in detail to me  
 The investigator has been explained about the nature of the study. 
 My rights and responsilities have been explained to me by the Investigator. 
 I agree to co-operate with the investigator and I will inform to her 
    immediately if I suffer from any unusual symptoms. 
 I am aware of the fact that I can opt out of the study at anytime without 
having to give any reason and this will not affect my Future treatment in 
this hospital. 
 I hereby give permission to the investigators to release the Information 
obtained from me as a result of participants in this study to the regulatory   
authorities, Government agencies and Institutional   Ethics   Committee.  
I understand that they are publicly presented. 
 My identity will be kept confidential if my data are publicly presented. 
 I am aware that if I have question during this study, I should Contact the 
concerned investigators. 
 
«««««««««««««««««««««« 
 
 
Signature of the Investigator  Signature of the Participant 
                                
                 Date         Date 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
  
 
